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1.1. MEMBRANE BUDDING: FROM COMPLEXITY OF INTRACELLULAR 
TRAFFICKING TO THE RELATIVE SIMPLICITY OF VIRAL PARTICLE 
CREATION 
 
1.1.1. Classical coated vesicles and novel membrane microdomains 
 
 Until the 1960’s the eukaryotic cell membrane was considered a static structure. It 
was thought that the cell membrane’s principal functions were to separate cellular 
contents within intracellular compartments and from external media, and to provide a 
template for protein reactions. In the mid 1960’s George Palade and James Jamieson, 
during their electron microscopy (EM) studies on protein secretion, observed specialized 
invaginations in the plasma membrane (Jamieson and Palade, 1967a, b). The 
invaginations were covered by electron dense material on the cytoplasmic side, and 
moreover, vesicles with similar external coats were seen in close proximity to these 
invaginations, suggesting that these membrane structures are intermediates of the same 
process (Jamieson and Palade, 1967a, b). Inspired by these observations, the authors 
proposed what is now known as the vesicular transport hypothesis (Palade, 1975). This 
hypothesis states that molecules move from one subcellular compartment to another via 
shuttling vesicular transport (Bonifacino and Glick, 2004). Today we know that budding 
of membrane vesicles is ubiquitous in the life cycle of eukaryotic cells, where exocytic 
and endocytic transport vesicles are constantly generated to carry cargo and membrane 
components between different cellular compartments (Mallabiabarrena and Malhotra, 
1995). These observations gave a new function to biological membranes as a dynamical 
component of the intracellular biochemical pathways which supports the bulk of the 
molecular transport and exchange.  Thus, understanding the different mechanisms that 
cells use to perform and control vesicle budding is essential for understanding the 
fundamental principles of origin and life of eukaryotic cells (Svetina, 2007) (Figure 1). 
 
Figure 1. Types of cellular budding: electron microscopy imaging in cells. Inward cellular vesicle 
formations are shown in (a), where clathrin coated pits are seen with the clathrin lattice outside of the 
vesicle membrane (Marsh and McMahon, 1999) (bar 50 nm); in (b), where COP coated vesicle is shown1 
and in (c) where caveolae formation is represented (Parton and Simons, 2007). Outward vesicle formation 
is characteristic for MVB and viral budding. In MVB it is likely driven by the protein Snf7, which 
overexpression in cells gives rise to spiral-like structures formation on the plasma membrane as can be seen 
in (d) (Hanson et al., 2008). The MVB formation may be observed in (e) (Stark et al., 1988). Viral budding 
of many enveloped viruses is driven by their matrix protein (f) (Whittaker, 2001). 
 
 In the 1970s the vesicles visualized by Palade were isolated and the major 
component of their coat was identified as the protein clathrin. In the 1980s another type 
of coated vesicles was discovered: the COPI-coat vesicles were identified in the Golgi 
stack. In the 1990s COPII-coated vesicles were co-localized within the endoplasmic 
reticulum (ER) and were added to the list of vesicle protein coats (Robinson, 1997). Since 
clathrin’s discovery, innumerable research papers and reviews have appeared talking 
                                                 





                                                
about the three rigid scaffolds2 paradigm in vesicular trafficking (clathrin, COPI and 
COPII). Still, the molecular mechanism of the formation of coated vesicles has not been 
decoded completely because these vesicles are deeply involved in a great variety of 
protein and lipid networks. The enormous complexity lying behind the budding of coated 
vesicles is naturally related to the need for precise regulation of intracellular protein 
trafficking mediated by such vesicles. 
 
However, basic principles underlying the creation of a spherical membrane 
geometry by protein coats are well understood. Both clathrin and COPII proteins produce 
basket-like structures in solution, demonstrating their intrinsic ability to self-assemble 
into spherical coats (Antonny et al., 2003). On-membrane polymerization of a clathrin 
coat depends on membrane curvature, which is produced by adaptor proteins, such as 
AP180 or epsin, through amphipathic helix insertion into the outer leaflet of the lipid 
membrane (McMahon and Gallop, 2005). In the absence of adaptors, clathrin forms plane 
lattices which were observed by EM on a flat membrane surface (Ford et al., 2002). 
Mechanisms underlying polymerization of spherical clathrin cages in the presence of 
adaptor proteins continue to be extensively studied (McMahon and Mills, 2004). The 
number of possibilities is growing exponentially as more and more adaptor proteins are 
discovered, each one bringing a new level of complexity into models describing the 
clathrin coat formation. Similar problems appear in the COP systems (McMahon and 
Mills, 2004). However, production of a rigid protein scaffold is not the only way that 
cells use to produce curvature needed for their functioning. 
 
 In 1953 Palade (and Enichi Yamada two years letter), discovered another type of 
highly curved membrane objects in cells: the caveolae (Palade, 1953; Yamada, 1955). 
Caveolae appear as structures resembling “little caves”, which are vesicular invaginations 
of the plasma membrane 50-100 nm in size. It was only in 1992 when caveolin, the major 
protein component of caveolae, was identified and described as deeply inserted into the 
outer monolayer of the caveolae membrane (Rothenberg et al., 1992). This discovery 
 
2 The term rigid scaffold or rigid coat is used in the recent literature to define a vesicle covered by a protein layer formed by 
oligomerization of proteins anchored to the outer monolayer of the vesicle membrane via partial insertion of a hydrophobic 
hub or via interaction with a membrane-inserted adapter-protein. When the rigidity of the clathrin scaffold was measured (Jin 
et al., 2006), it was found that the coat that clathrin forms in solution is close in rigidity to a plane membrane vesicle.   Thus 
the hypothesis of a “rigid scaffold” imposing its intrinsic shape on a lipid membrane should be taken with caution. 
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allowed for a characterization of caveolae from chemical and biophysical points of view. 
Based on their lipid composition and topological behavior caveolae are considered to be a 
subtype of “membrane domains” that form invaginations and are capable of endocytosis 
and transcytosis (Couet et al., 2001). The presence of a high amount of caveolin which is 
capable of inserting its hydrophobic hairpin-like domain inside the lipid matrix and forms 
a tight 1:1 complex with cholesterol (Martin and Parton, 2005), might indicate a new type 
of protein-lipid interaction within budding membrane domains. In this case the budding 
does not rely on multiple adaptors or signaling lipids, but on the interaction between 
protein molecules and protein-lipid moieties. Caveolin was not reported to form baskets 
in solution, so its ability to impose curvature is revealed only in the presence of the 
membrane matrix. The molecular basis of this new type of membrane deformation is yet 
to be elucidated, but it is logical to assume that the driving force of this new type of 
budding is hidden in the caveolin self-organization on a membrane surface.  
 
Caveolin provides a new paradigm for curvature creation by proteins deeply 
embedded into lipid bilayer of cellular membrane where they form specialized budding 
domains transforming into invaginations and vesicles. In the last decade other proteins 
utilizing similar mechanisms of membrane remodeling have been discovered. They 
include the reggie/flotillins protein family characterized by a highly conserved prohibitin 
homology (PHB) domain which has a hairpin-like structure similar to the membrane 
domain of caveolins (Voeltz et al., 2006). These proteins share other similarities: they 
generally partition into detergent resistant membranes, form oligomers, contain several 
phosphorilation sites and are typically localize in regions of high curvature (Bauer and 
Pelkmans, 2006). However, they also demonstrate interesting differences related to the 
dynamical properties of created membrane formations. Caveolins form relatively stable 
invaginations, caveolae, which usually consist of a cluster of vesicles indicating a 
difficulty in a vesicle detachment. Flotillins have been recently demonstrated to be more 
dynamic, producing large numbers of intralumenal vesicles (Frick et al., 2007). This 
novel mechanism of vesiculation has been discussed broadly in the recent literature 
(Langhorst et al., 2005).  
 
It might be that caveolin and other membrane-embedded proteins interact with 
membrane lipids much more intimately that coat proteins. However, the last decade of 
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research on cellular membrane budding, both theoretical and experimental, has revealed 
lipids to be active participants of the budding process in general. To mention several 
examples, clathrin and COP assembly progress only if specialized charged lipids are 
present in the lipid membrane; especially important are the lipids of phosphatidylinositol 
(PI) family (McMahon and Gallop, 2005). Specialized lipids are involved in regulation of 
on-membrane association of membrane-embedded proteins, such as caveolin. This 
involvement is likely related to the ability of these molecules to form, transiently or 
constitutively, microdomains in the plasma membrane (Martin and Parton, 2005). 
Cholesterol is an important membrane molecule. Its ability to intercalate into the lipid 
bilayer and change various characteristics of the membrane together with its high 
concentration in some biological membranes, all suggest that cholesterol is one of the 
most important membrane moieties. For both, clathrin and caveolin dependent 
endocytosis, cholesterol’s presence has been found to be a requirement (Baba et al., 
2001). However, it is not known whether cholesterol is transported to the budding sites 
by the proteins themselves or cholesterol-enriched membrane domains attract specialized 




1.1.2. Budding to the opposite direction: multivesicular body and viral 
budding 
 
When thinking about vesiculation, the final topological organization of the vesicle 
should be taken into account. Members of both classes of curvature creating proteins 
presented above assemble onto the outer surface of the vesicle membrane. However, 
several cellular processes occur as a topological antipode of these mechanisms, i.e. 
proteins responsible for budding remain in the inner membrane monolayer, thus driving 
membrane budding in an outward direction (from the cytoplasm). This difference in 
directionality is directly related to the sign of the curvature created by the proteins: while 
coat proteins bend membranes with positive curvature (the sign is traditionally defined 
for the monolayer with bound proteins) the proteins inside a vesicle produce negative 
curvature. Two of the most representative examples of such a budding with negative 
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curvature are multivesicular body (MVB) formation and the budding of enveloped 
viruses.  
 
The MVB consists of mid-stage endosomes containing hundreds of small (~50 
nm) intralumenal vesicles (ILVs). The destiny of most of ILVs is in lysosomes, were 
their “cargo” of transmembrane proteins and lipids is degradated (Babst, 2005; Hurley, 
2008). In recent years many proteins necessary for ILVs formation have been discovered. 
At least 18 members of the endosomal sorting complex required for transport (ESCRT) 
were identified as participants in ILV creation, though no definite mechanism unifying 
various interactions of these proteins and the process of ILV budding has been proposed 
(Hanson et al., 2008). ESCRT proteins can be separated into three complexes, two of 
which are possible candidates for recruitment of the ubiquinated cargo that has to be 
recycled or degradated. The third complex, consisting of four proteins, is thought to 
promote the membrane bending and budding of ILVs itself (Hurley, 2008). As discussed 
early, proteins conducting membrane budding usually remain associated with the vesicle 
membrane. In the case of ESCRT pathway and ILV formation there has been no 
structural evidence for association of protein complexes with ILVs. Interestingly, Hanson 
and collaborators have recently shown that even without upstream regulatory factors, the 
overexpression in cells of Snf7, a protein from ESCRT-III, is enough to form uniform 
circular structures that can drive formation of buds and tubules (Hanson et al., 2008) 
(Figure 1D).  This indicated a new type of budding mechanism, where cooperativity 
between the protein and its coordinated action on the bilayer lipid membrane (BLM) 
leads to the formation of vesicles lacking any protein coat or lining.  
Lipid analysis of MVB revealed the presence of a small amount of a very rare 
lipid, LBPA, which was shown to be able to promote budding of lipid membranes by 
itself, without protein involvement (Matsuo et al., 2004). This lipid may appear in the late 
endosomes due to the action of some specialized enzymes, thus reversing the signaling 
and acting functions between lipids and proteins. On the other hand, phosphatidilinositols 
are required entities for the recruitment of ESCRT family proteins to the membrane 
during ILV formation (Hurley and Emr, 2006). It is interesting that different PI moieties 
are present during different stages of the endocytic pathway, thus indicating a very 




Budding of enveloped viruses is topologically similar to ILVs formation. Most 
non-enveloped viruses exit their host cells by lysis, which is a cell destructive 
mechanism. However, enveloped viruses chose another, more efficient, way of 
replication via membrane budding, where the integrity of the host cell membrane is 
preserved and the host is not necessarily killed (Welsch et al., 2007). Most viruses, such 
as retroviruses, alphaviruses, rhabdoviruses, and ortho- and paramyxoviruses, bud 
predominantly from the surface (plasma membrane) of the infected cell, but various 
intracellular organelle membranes were also shown to provide a platform for viral 
budding, thus resulting in the accumulation of viral particles in the lumen of such 
organelles (Welsch et al., 2007). Many viruses, like the Human Inmunodeficiency Virus-
1 (HIV-1), may hijack cellular machinery to help themselves to egress (Chen and Lamb, 
2008). In this way, for example, HIV was proposed to bud into the MVB of 
macrophages. However, recently, the role of intracellular compartments in HIV budding 
has been questioned and it has been proposed that the intracellular pool of viruses 
observed by EM mainly represents re-internalized particles that have originally budded 
from the plasma membrane (Jouvenet et al., 2006).  
Whichever is the case, the notion that HIV and some other viruses interact with 
the members of the ESCRT machinery is now widely accepted, but there is no consensus 
about the exact role which ECSRT proteins play in virus formation (Chen and Lamb, 
2008). One possibility is that ESCRT proteins participate in membrane fission in the 
terminal stage of viral egression. This hypothesis is further supported by the fact that 
ESCRT-related proteins were found to participate in another cellular process involving 
membrane division: the abscission during cytokinesis (Chen and Lamb, 2008). This 
finding may be an indication of a universal role for ESCRT proteins in cellular membrane 
fission finalizing inward membrane budding. If so, viruses may use the ESCRT 
machinery and the proteins known to disassemble the ESCRT III complex (the AAA-
ATPase Vps4) to boost the efficiency of their budding. Nevertheless, this has not been 
demonstrated directly.  
 
Despite possible interferences from a host cell, enveloped virus particles include 
only small traces of cellular proteins (Briggs et al., 2003), thus suggesting that this type 
of viruses ultimately rely on their own protein machinery for vesicle egression.  Two 
principal mechanism of viral budding mediated by viral membrane proteins may be 
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distinguished. Budding can be led by viral transmembrane glycoproteins, shown to be 
sufficient for the formation of virus-like particles in the absence of any other viral 
component. This is the case for budding of viruses such as Influenza, Semliki Forest or 
Hepatitis B. Another mechanism of viral budding relies on the matrix proteins of the 
virus (Welsch et al., 2007). Matrix protein is the major component of most enveloped 
viruses. This protein forms a tightly packed shell just beneath the lipid membrane of the 
virus, which resembles the caveolin coat of the endocytic vesicles, but with an opposite 
topology. Budding of most retroviruses (except Foamy Virus) and many paramixoviruses 
is exclusively driven by this core protein3. There are some exceptions where other viral 
proteins or other protein combination are the minimal requirements for budding (Welsch 
et al., 2007). 
 
The lipid composition of the cellular membrane can differ significantly from the 
viral one. It was proposed that some viruses bud selectively from membrane 
microdomains enriched by sphingomielin and cholesterol (“rafts”), as in the case of 
caveolin budding (Simons and Ehehalt, 2002). Lipidomics analysis of some viruses such 
as HIV (Brugger et al., 2006) or influenza (Polozov et al., 2008) indeed revealed a 
prevalence of raft-forming components: cholesterol, sphingomyelin and phospholipids 
with saturated side chains. However, as in the case of caveolin budding, is it not known 
whether those microdomains are virus-induced or preexisting in cell membranes.  
 
In conclusion, all the budding processes that have been reviewed are based in 
protein-lipid interactions of different complexity levels, which lead to similar bending of 
the lipid matrix toward one preferential direction. Thus, to be able to understand the 
mechanisms behind the budding processes in cells, we have to take into account all the 
energy requirements to bend and bud a pure lipid membrane. 
 
3 In the case of retroviruses, matrix protein has been named Gag protein. 
1.2. PHYSICAL-CHEMICAL PRINCIPLES BEHIND LIPID MEMBRANE 
BUDDING 
 
1.2.1 Phospholipids and their polymorphism 
 Phospholipids are the major component of biological membranes. These 
molecules consist of a hydrophilic polar head group containing one or more phosphate 
groups and a hydrophobic tail, made up of two fatty acyl chains (Figure 2). The 
phospholipids polymorphism is exhibited in their ability to form different structures or 
phases through their aggregation into a monolayer (Epand, 2007). Such phases are often 
characterized by spontaneous or intrinsic curvature of the lipid monolayer defined as the 
curvature that a lipid monolayer adopts in solution in the absence of any external forces 
(Zimmerberg and Kozlov, 2006). Hence, lipids may be classified into three different 
classes based on the intrinsic curvature of the aggregated monolayer, which can be 
positive, zero or negative. For details and examples of the phases or shapes formed by the 
different phospholipids, see Table 1. The factors that determine the curvature preference 
are many. Among the most important ones are the lipid molecular structure, which will 
dictate the steric interactions between lipid head and acyl chains; hydrogen bonding or 
charge repulsions among head groups; hydratation of the lipid heads or temperature 
transitions, etc. (Epand, 2007). Phase transitions of several typical lipids are presented in 
Table 2.  
 
Figure 2. Phospholipid structure. Molecular and schematic representation of a phospholipid4. 
 
                                                 




Table 1. Classification of the lipid monolayer spontaneous curvature and resulting phases. 
 
Table 2. Polymorphic phase preferences of unsaturated lipids 
(Gruner et al., 1985) 
 
 As seen from Table 1, while in solution, lipids may form spontaneously not only 
planar bilayers (lamellar phase) characteristic for lipids such as DOPC, but also other 
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highly curved structures such as a micellelar phase (typical for lysolipids) or a hexagonal 
phase (as in case of DOPE). Hence, if a bilayer is formed from two monolayers the 
spontaneous curvature of the resulting bilayer5 will depend on the spontaneous curvatures 
of the monolayers. Here three conditions may take place. a) If the bilayer is combined 
from two symmetrical monolayers with small and the same sign of spontaneous 
curvature, the resulting bilayer will be planar, due to mutual compensation of 
spontaneous curvatures of the monolayers. b) If the intrinsic curvature of the constituting 
monolayers is two high, the bilayer will not form at all, due to accumulation of curvature 
stress. c) If monolayers with two different spontaneous curvatures are combined, the 
resulting bilayer will have a spontaneous curvature with the sign of the monolayer with 
the more negative spontaneous curvature (Mouritsen, 2005) (Figure 3). 
 
Figure 3. Lipid bilayer curvature is dictated by the spontaneous curvature of its monolayers. In (a) the 
three types of lipid monolayer curvature are represented. If a bilayer is formed from two of such 
monolayers, the following outcomes are possible: if two monolayers with zero curvature are combined, a 
lamellar phase will be formed, as can be seen in (b). Two monolayers with the same positive curvature will 
also form a bilayer, however, if the intrinsic curvature of the monolayers is too high, the accumulated 
curvature stress will not allow for lamella formation (c). The same situation is present in the case of two 
monolayers with same negative curvature (d). If two monolayers of different curvature are combined, the 
resulting bilayer will have an average curvature as represented in (e). 
                                                 
5 Here we assume that the resulting bilayer is not a closed structure (such as a vesicle). Thus, the difference of the areas of the 
monolayers (area mismatch) is neglected. 
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 The spontaneous curvature of the bilayer lipid membrane represents the initial 
state from which the budding may occur. The bending energy at this point is a minimum 
and to change this spontaneous membrane state work should be applied. 
 
 
1.2.2. Energetics of membrane budding 
  
 Being a two dimensional liquid crystal, the bilayer lipid membrane has bending 
rigidity or stiffness opposing bending in the normal direction to the membrane plane 
(Zimmerberg and Kozlov, 2006). Thus, to produce a membrane bud certain forces should 
be applied to the membrane. Also, while transforming a “plane” membrane connected to 
a lipid reservoir (e.g. to a large membrane) into a “spherical” vesicle, there is an area 
increase, indicating that some lipids have to be transported to the budding site. This event 
also requires energy to work against the membrane lateral tension (Mouritsen, 2005).  
Thus, the requirement to deform a lipid membrane into a bud is to apply enough energy 
to overcome membrane resistance due to its bending rigidity and lateral tension. The 
energy related to the lateral tension of the membrane will depend on the bud area. The 
bending energy, having a more complicated nature, will depend on the initial and final 
states of the system, which needs to be defined in relation to the spontaneous and final 
curvature of the membrane.  
 
 
1.2.2.1. Bending energy 
 
The energy required to bend a membrane depends on the membrane curvature 
deviation from the spontaneous state of the system, in which the energy is equal to zero 
by definition. In a general case, this bending energy will depend on the two principal 












where Csp is the spontaneous curvature of the membrane,  R1 and R2 are the local 
curvature radii, A is the membrane area and k is the bending modulus (Helfrich, 1973). 
For typical phospholipid bilayers, k ≈ 20 kBT, where kB is the Boltzmann’s constant and T 
is the temperature expressed in degrees Kelvin. kBT (≈ 4.1 x 10-21 J) is the thermal energy 
(Reynwar et al., 2007) and is frequently used to represent the energy requirements for a 
given process. When the formation of a spherical vesicle is considered, both curvature 
radii will be equal. This way, if zero spontaneous curvature is assumed, the total energy 
required to bend a membrane in order to form such vesicle will be independent of the 










1 222 ≈=×=+= ∫ ππ  (2) 
 
If this total bending energy is recalculated per lipid molecule in the area of 
geometrical transformation, it becomes clear that the process requires much more energy 
per molecule to produce small radii vesicles, than to produce larger vesicles. This way, 
the energy per lipid molecule required to create a vesicle of 50 nm in diameter will be 
approximately nine times bigger than the energy required to create a 150 nm vesicle. 
Thus, the protein action will be required to allow for the formation of the small vesicles 
that are characteristic for different cellular vesiculation processes. This way, the energy 
applied to the membrane during the polymerization of the clathrin “rigid” basket is of the 
same order of magnitude as the bending energy needed to produce a spherical vesicle 
with the typical diameter of a clathrin coated pit (Jin et al., 2006). These similarity render 
the process of formation of vesicles by clathrin coating alone mostly probabilistic. Thus, 
the insertion of clathrin adaptors into the membrane leaflet induces the necessary 
spontaneous curvature of the membrane (Jin et al., 2006) and considerably lowers the 
energy threshold.  
 
As discussed above, lipids and proteins may induce membrane curvature by 
mechanisms other than bending by rigid scaffolds. The curvature can be imposed via 
alterations of spontaneous curvature of the monolayers by hydrophobic insertions 
(Zimmerberg and Kozlov, 2006). Spatial coordination of such insertions by attractive 
interactions mediated by membrane undulations creates membrane areas of increased 





membrane domain to bud does not generally require alterations of the spontaneous 
curvature of the membrane. Domain budding is also driven by another force, line tension 
associated with the domain boundary (Lipowsky, 1992).  
 
 
1.2.3. Domain structure of biological membranes and its role in membrane budding 
  
 The first step in understanding biological membranes was the 
development of the “fluid mosaic model" by Singer and Nicolson in 1972, which unified 
the findings and ideas of the preceding decade (Singer and Nicolson, 1972). In this model 
the lipids are seen as a sea in which many monomer proteins float unencumbered and the 
bilayer surface is exposed directly to the aqueous environment (Figure 4d). Although, this 
model became a standard conceptualization for membrane architecture, the ideas it 
represented are somewhat misleading. The idea that proteins are present at low 
concentration and dispersed in the lipid matrix has been questioned in the last decade; 
many studies showed a preferential association of protein molecules in the membrane 
plane (Engelman, 2005). Numerous findings during the last decades allowed for the 
emerging of the modern membrane concept where the membrane is seen with variable 
patchiness, variable thickness and higher protein occupancy than has generally been 
considered (Engelman, 2005) (an evolution of the biological membrane representations 
can be seen in Figure 4). Thus, the randomness of the two-dimensional liquid, presented 
by the “fluid mosaic model” has to be reviewed, and membrane fluidity has to be 
reconsidered with local organization into membrane patches or domains.  
As described earlier, membrane lipids aggregate into different forms or phases. 
They, also, may undergo transitions between phases of different morphology that can be 
triggered by changing the water concentration under isothermal conditions (Mouritsen, 
2005). In addition to this kind of transition, lipid aggregates, such as lipid bilayers, may 
undergo a number of internal phase transitions. These types of two-dimensional 
transitions are the basis of the formation of lipid membrane domains.  
 
 
Figure 4. Historic picture gallery of membrane models (Mouritsen, 2005). (a). Gortel and Grendel 
shown that the membrane is very thin, being only two molecules thick (Gortel and Grendel, 1935). (b). The 
notion of the association of membrane proteins with the lipid bilayer was introduced by Danielli and 
Davson (Danielli and Davson, 1935). (c). Robertson presented a related version of membrane organization, 
were membrane proteins are represented as layers sandwiching the lipid bilayer (Robertson, 1966). (d). A 
standard conceptualization of membrane architecture as fluid-mosaic membrane was proposed by Singer 
and Nicolson in 1972 (Singer and Nicolson, 1972). (e). A refined membrane model was proposed by 
Israelachvili, where the need of membrane proteins and lipids to adjust to each other, pore formation, 
membrane folding, thickness variations and heterogeneity were took into account (Israelachvili, 1977). (f). 
The importance of the cytoskeleton and glycocalix were introduced in the Sackmann's model (Sackmann, 
1994). The latest version of the model, proposed by Engelman, can be seen in (g), where the variable 
patchiness, variable thickness and higher protein occupancy than has generally been considered are 
represented (Engelman, 2005). 
  
 
When more than one type of lipid molecules is present in a bilayer, the strong 
attraction interaction between species of the same kind may lead to the loss of 
translational mobility of the lipids (Mouritsen, 2005). As a result, a local transition from 
liquid phase (the fluid phase of the biological membrane) to a crystalline or solid phase 
occurs. When this new phase separates from the fluid phase of the membrane, the 
resulting membrane lipid domain may have a very different shape, but usually this 
domain is non-circular (Table 3). Another type of phase transition is intrinsic to the fluid 
phase of the membrane. This phase transition does not affect the translation motions of 
the lipid molecules, but produces long range ordering of the lipid tails. In this way a 
liquid ordered phase emerges. The result of this type of transition is the formation of 
circular domains which minimize their boundary energy, as will be discussed below 
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(Table 3). A general example of such liquid ordered domains is the lipid raft enriched in 
cholesterol and sphingomyelin. (Simons and Vaz, 2004). 
 
Table 3. Crystalline versus Fluid-like domains (Baumgart et al., 2003; 
Li and Cheng, 2006; Yanagisawa et al., 2007). 
 
Both, crystalline and liquid ordered domains embedded into the liquid disordered 
bilayer membrane, may lead to bud formation. In the case of the crystalline phase, 
membrane curvature may result from a tendency of the crystalline phase to grow in a 
direction normal to the membrane plane. However, this type of crystalline domain 
budding has not been observed in lipid systems. In contrast, the budding of lipid liquid 
ordered domains has been documented (Baumgart et al., 2003).  
 
In 1992, Reinhard Lipowsky proposed a new force responsible for the budding of 
fluid membrane domains (Lipowsky, 1992). He argued that a flat circular domain does 
not represent the state of lowest energy, since the length of the domain edge can be 
further reduced if the domain deforms into the third dimension and forms a bud (Figure 
5). Lipowsky proposed a simple theoretical model, which predicted that liquid ordered 
domain should undergo budding as soon as it achieves to a certain limiting size and the 
edge energy of the domain becomes larger than the bending energy of the membrane. In 
his pioneering work Lipowsky made another important prediction: if the budding domain 
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is symmetrical (and, consequentially has zero spontaneous curvature), budding may 
proceed in both directions normal to the membrane plane. However, if the budding 
domain has non-zero spontaneous curvature, which implicates an asymmetrical 
distribution of compounds between the monolayers, budding will proceed toward one 
preferential direction dictated by the initial domain curvature.  
 
Figure 5. Budding of a phase separated circular domain (red) embedded in the membrane matrix (blue). 
The length of the domain edge decreases during the budding process from (a) to (b)6. 
 
These theoretical predictions can be directly applied to biological membranes. It 
is quite natural to assume that proteins can exercise control over the budding of fluid 
membrane domains. For example, the effect of a protein hydrophobic insertion into a 
lipid leaflet that changes the local curvature of that leaflet (McMahon and Gallop, 2005). 
However, if such proteins oligomerize on the membrane domain, the global curvature of 
the domain will be affected and the directionality needed in cellular processes will be 
granted (Zimmerberg and Kozlov, 2006). Other possible roles of proteins in the budding 
of membrane domains involve cholesterol segregation, which allows for the formation of 
such domains (Kirkham and Parton, 2005). Finally, proteins themselves are amphipathic 
moieties capable of forming monolayers (Boucher et al., 2007) and, perhaps, segregate 
into fluid domains on the membrane surface.  
 
These possibilities have not been explored well experimentally. The main 
limitation has been the lack of simple model systems that allows one to probe the role of 
different protein components involved in domain driven budding in cells. Such a system 
is expected to help identifying the molecular players and mechanisms of budding, as was 
successfully demonstrated in reconstituted model systems for “rigid” coats (Higgins and 
                                                 





McMahon, 2005). Probably, one of the simplest budding event in a cell is the budding of 
an enveloped virus (for example, Newcastle Disease Virus) driven by its matrix protein. 
Thus, if other cellular mechanisms are not critical for the budding activity of this protein, 
the reconstitution of budding with the matrix protein in different model lipid system will 
lead to the understanding of the molecular mechanisms behind the viral budding and 
most likely will provide new insights into the mechanisms of cellular budding. The role 
of the membrane domain formation in the budding of enveloped viruses also may be 
verified using this kind of reconstitution systems, as the involvement of fluid-like lipid 
rafts in the budding of some viruses has been established (Simons and Vaz, 2004). Thus, 
the purpose of this work is to create a reconstituted model system(s) and to study the 




1.3. NEWCASTLE DESEASE VIRUS AND ITS MATRIX PROTEIN 
 
1.3.1. Newcastle Disease Virus: classification and characteristics 
 
Newcastle Disease Virus (NDV) has been assigned by the International Committee 
on Taxonomy of Viruses (ICTV) to the genus 01.048.1.05, where 01 stand for order 
Mononegativirales (e.g. genome is not segmented and contains a single molecule of 
linear negative-sense, single-stranded RNA), 01.048 refers to the family 
Paramixoviridae, 01.048.1 refers to the subfamily Paramixovirinae and 01.048.1.05 to a 
recently formed genus of Avulavirus, which is represented by NDV and Avian 
Paramixoviruses7. The virus is roughly spherical, with a diameter between 150 to 500 
nm; however the virus may appear as a filamentous particle of approximately 100 nm and 
variable length (Yusoff and Tan, 2001). The membrane envelop is derived form the host 
cell membrane. The virus has a negative-sense, single-stranded RNA genome which 
contains codes for an RNA-directed RNA polymerase (L), hemagglutinin-neuraminidase 
protein (HN), fusion protein (F), matrix protein (M), phosphoprotein (P) and  
nucleoprotein (NP) in the 5’ to 3’ direction (Alexander et al., 1997) (Figure 6).  
 
Figure 6. Paramixoviridae structure. (a) Three-dimensional image of Pneumovirus reconstruction 
originated by the University of Warwick, Pneumovirus Laboratory, UK. Matrix protein, shown in blue, 
orchestrates the virus formation. RNP complex attaches to the matrix core, which at the same time is 
associated to the lipid membrane and to the transbilayer glycoproteins such as the fusion protein7. (b) Real 
micrograph of a NDV particle after negative staining. Scale bar 25 nm (Russell and Almeida, 1984). 
                                                 
7 ICTVdB - The Universal Virus Database, version 4. http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/ 
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All the steps of this virus replication cycle take place in the cytoplasm (Takimoto and 
Portner, 2004) (Figure 7). After the HN glycoprotein binds to its receptor on the cell 
surface, the F protein induces pH-independent fusion of the viral envelope with the 
plasma membrane of the infected cell. Then the viral nucleocapsid dissociates from the M 
protein core by an unknown mechanism and is released into the cytoplasm of the cell 
(Takimoto and Portner, 2004). The viral polymerase complex (P-L) transcribes each gene 
in the RNA template, and thus antigenome synthesis begins (Curran and Kolakofsky, 
1999).  
 
Figure 7. NDV replication cycle. Virions attach via specific receptors located on the surface of cell 
membrane and enter host cells via fusion of the viral envelope with the host cell plasma membrane in an 
environment of neutral pH. The viral genome is transcribed processively from the 3' end by virion-
associated enzymes. The genome replicates in the cytoplasm. The parental genome does not serve as 
template; Replication is independent of the host nuclear functions. The assembly and egression of the virus 
is independent of the nucleocapsid (Yusoff and Tan, 2001). 
Viral assembly takes place in the plasma membrane of infected cells, where M 
protein seems to have a key role (Takimoto and Portner, 2004). All the viral components, 
i.e. nucleocapsid, M protein, and envelope glycoproteins F and HN are transported to the 
plasma membrane where virions are assembled during the process of budding. The 





                                                
other cellular proteins largely excluded from the final viral particle. M proteins clustering 
on the inner surface of the host cell’s plasma membrane concentrate F and HN proteins as 
well as the ribonucleocapsid at the site of virus assembly (Takimoto and Portner, 2004). 
Interaction of M proteins with the cytoplasmic tails of the envelope glycoproteins is 
believed to be important for specific incorporation of the glycoproteins into the virion: 
mutation in the NDV matrix protein can result in decreased F protein incorporation into 
the particles and, thus, decreased infectivity (Peeples and Bratt, 1984). Moreover, the 
insertion of the viral genome into the virion is dependent on the interaction between 
matrix protein and the nucleocapsid complex. In this way, M protein presence at the 
budding site is a prerequisite for virus assembly (Yusoff and Tan, 2001).  
 
Newcastle Disease virus is an avian virus that causes the Newcastle Disease (ND) in a 
wide host range with 27 to 50 orders of birds reported to have been infected (Alexander, 
2000). This disease was discovered for the first time in East Indies in 1926, but it is 
named after Newcastle-upon-Tyne, England, where it was rediscovered a year later in 
1927. Since 1927 this virus was responsible for many severe epidemics that caused death 
to thousands of wild and domestic birds, together with the economical impact to the 
poultry industry (Lomniczi et al., 1998). The virulence varies with virus strain. 
Accordingly, NDV strains may be classified into lentogenic or low virulence viruses, that 
cause mild respiratory or enteric infections; mesogenic strains or intermediate virulence, 
that cause respiratory or nervous signs with moderate mortality; and velogenic strains, 
that cause severe intestinal and/or neurologic disease resulting in fast and high mortality 
(Seal et al., 2000).  
 
NDV is closely related to human paramixoviruses such as measles, mumps, human 
parainfluenza or respiratory syncytialvirus and distantly related to the lethal filoviruses, 
Ebola, Marburg or Rabies virus8. But surprisingly, NDV causes only minor illness in 
humans, limiting its manifestation to mild conjunctivitis and mild influenza-like 
symptoms. Moreover, this virus has certain characteristics that make it suitable for 
therapeutic applications. Recently NDV was proposed as a promising vaccine against the 
highly pathogenic avian influenza virus (HPAIV), which has a 60% mortality rate in the 
 




                                                
human population (DiNapoli et al., 2007). The development of vaccines against this 
virulent virus were impeded due to its low immunogenicity, the high quantities of killed 
vaccine required, and risk of genetic exchange of a live vaccine with circulating influenza 
virus strains.  Thus, NDV appeared as a perfect candidate for this vaccine, due to its 
negligible incidence of recombination. In their recent work, DiNapoli and coauthors used 
recombination genetics to generate a recombinant NDV as vaccine against HPAIV. They 
demonstrated reduction or complete prevention of transmission of the HPAIV virus in 
monkeys (DiNapoli et al., 2007). Although this result is of great interest, the use of a 
virus as a vaccine against another virus should be taken with extreme caution, as the 
exact mechanisms of cell and viral cycles are not yet well established (Han et al., 2008) 9. 
 
NDV has been the object of another type of breakthrough study, where its ability to 
replicate 10,000 times faster in tumor cells versus normal cells was explored (Adams and 
Prince, 1957). NDV oncolytic properties were discovered in the late 50s, and since then, 
NDV was actively studied as a potential antitumoral agent (Horvath et al., 1999). Viral 
oncolytic therapy has two principal ways of application: one is an indirect increase of 
antitumor immunity through a modulation of the immune response and another is a direct 
treatment of tumors with replicating, oncolytic viral vectors. In this aspect, reverse 
genetic technology enables generating recombinant NDV strains with therapeutic genes 
encoded to enhance the oncolytic properties inherent to some native NDV strains (Janke 
et al., 2007; Vigil et al., 2007; Puhler et al., 2008). As a result, tumor cells begin to 
express the apoptotic or danger signals what stimulate the activation of the immune-
system response against this infected cells. In the direct oncolytic mechanism, however, 
the natural viral cycle results in complete lysis of host cells. This cycle can then repeat 
itself with the progeny virion infecting adjacent tumoral cells and destroying them by 
replication (Mullen and Tanabe, 2002). Thus identification of the proteins responsible for 
NDV formation and budding and a deeper understanding of the budding mechanism are 




9 In the recent article by Han and coauthors, the widely accepted notion that NDV lack recombination was questioned. The 
authors found a new natural multi-recombinant strain of NDV, the result of a combination of at least three another known strains, 




1.3.2. Matrix protein of Newcastle Disease virus: its known and unknown properties 
 
As mentioned above, matrix proteins of different negative-strand RNA viruses 
play a key role in the assembly and budding of the virions (Garoff et al., 1998; Takimoto 
and Portner, 2004). NDV matrix protein was proposed to orchestrate the virus assembly 
by interacting with the nucleocapsid protein (NP), regions of the transmembrane 
glycoproteins (the F-HN complex) and lipid bilayer (Yusoff and Tan, 2001).  
Unfortunately, the tertiary structure of NDV M protein has not been resolved yet, 
but its gene has been sequenced by Philip Chambers and coauthors in 1986 (Chambers et 
al., 1986). The authors showed that this protein consists of 364 amino acids, which 
corresponds to a polypeptide with a molecular weight of approximately 40 kDa. This 
protein contains 8% acidic and 14% basic amino acids. M protein has a net charge of 
+19.5 at pH 7.0, assuming a charge of +0.5 for the histidine residues. However, the basic 
residues are not uniformly distributed along the sequence, giving the N terminus of the 
protein an acidic character due to the presence of 100 somewhat acidic amino acids in 
this region (Chambers et al., 1986). Thus, its basic and acid charge distribution can 
mediate electrostatic interactions between different viral components, such as 
neighboring matrix proteins (Sagrera et al., 1998), the virus spike formers F and HN 
glycoproteins (Peeples and Bratt, 1984; Garcia-Sastre et al., 1989), or, the RNP complex 
from the virus interior (Garoff et al., 1998). The same electrostatic forces were reportedly 
involved in the interaction of M protein and a cellular protein actin, present in small 
quantity in the NDV virion and other enveloped viruses (Giuffre et al., 1982; Han and 
Harty, 2005). Actin filaments of the cell cytoskeleton may be the railways by which the 
virus transports its M proteins through the cytosol to the plasma membrane surface, as 
was shown recently for Gag protein from equine infectious anemia virus (Chen et al., 
2007).  
 
NDV M protein interacts non-electrostatically with lipid membranes. The non-
electrostatic character of M protein-lipid membrane interaction has been confirmed by 
protein binding to artificial liposomes, where no sensitivity to the presence of positively 
or negatively charged lipids in the membrane (such as stearylamine or PS) or ionic 
strength of the surrounding buffer was detected (Faaberg and Peeples, 1988). A 
hydropathy plot of the primary structure of NDV M protein revealed that M protein has a 
 
25 
hydrophobic character, but there is no region large enough to span the lipid bilayer; this is 
in good agreement with the location of the protein on the inner surface of the viral 
envelope (Li et al., 1980; Chambers et al., 1986). Strong hydrophobic M protein 
interaction with the lipid membrane was further showed to restrict the degree of rotation 
of lipid moieties in the membrane (Neitchev and Dumanova, 1992). Thus, M protein 
exhibits strong nonspecific binding to artificial lipid bilayers.  
However, this lack of lipid specificity is not reflected in the lipid composition of 
the virus, where enrichment of certain component, such as cholesterol or sphingolipids, 
has been observed (Laliberte et al., 2007). This suggests that membrane binding and 
membrane bending by M protein is not in a direct relationship, and/or that viral 
glycoproteins participate in the process of lipid selection in vivo. In relation to this, it was 
recently shown that the incorporation of functional HN-F complexes into NDV is 
dependent on the presence of cholesterol (Laliberte et al., 2007). Furthermore, the 
presence of traces of caveolin and flotillin, both having high affinity for cholesterol, in 
NDV particles was reported (Laliberte et al., 2007). How cholesterol is concentrated in 
the NDV envelop is still to be determined. To mention some possibilities, M protein may 
act as caveolin, concentrating the cholesterol in the budding sites, actin filaments may 
bring M protein to cholesterol enriched domains on the plasma membrane or viral 
glycoproteins might be delivered to the budding site in cholesterol-enriched domains. 
 
The ability of matrix proteins of different enveloped viruses to form Virus-Like 
particles (VLPs) when expressed in cells has been known for some time (Jayakar et al., 
2004; Takimoto and Portner, 2004). For NDV, VLP formation was shown recently 
(Pantua et al., 2006), when expression of M protein alone or in combination with NP, F 
and HN gave resulted in VLP formation (Figure 8). Any viral protein combination 
expressed in the absence of M failed to produce VLPs. This confirms the key role of M 
protein in the assembly and its requirement for the budding of NDV and other enveloped 
viruses.  
 
Figure 8. Electron microscopy images of different particles formed by NDV proteins expressed in cells. 
Particles from NDV infected cells (B1), M protein-expressing cells (M), or cells expressing NP, M F and 
HN proteins can be observed (Pantua et al., 2006). As can be seen, all the particles are of similar shape and 
size, thus confirming the requirement and sufficiency of M protein in the budding of NDV. 
Brought together, the strong lipid binding and the ability to produce VLPs in cells 
indicates that M protein possesses the energy and the functionality necessary to induce 
unidirectional membrane curvature and, possibly, membrane neck fission. However, as 
discussed previously, cellular components may also support M protein budding action. At 
this point, the proposed study of M protein interactions with model membrane systems 
should clarify the mechanism of membrane budding and establish a common pathway for 







   
In the last 50 years, the knowledge of the mechanisms of cellular membrane budding 
has been dramatically expanding. However, a deep understanding of the physical 
principles and molecular mechanisms of membrane rearrangements during the budding is 
still lacking. So far, we have identified many players, but we are just starting to elucidate 
the rules of the game. The best way to progress in this understanding is by using the 
simplest system and by trying to extend the knowledge obtained with such a system to 
more complicated ones. From this point of view, viral budding is, probably, the best 
candidate to start with. Although, viruses may sequester the cellular machinery to 
vesiculate more efficiently, their budding is not as tightly controlled as in the endocytic 
or endosomic case. Viruses have limited amount of proteins, making it easy to study 
protein interactions in depth. Moreover, as described above, it is already known that 
many viruses rely only on one protein for their budding.  Also, studying virus budding is 
of great interest to cell biology, as the identification of viral proteins involved and the 
mechanisms that viruses utilize to exploit cellular processes is expected to yield 
important insights in our understanding of the cell. Furthermore, the understanding of 
molecular mechanisms and the main driving forces of viral budding can suggest new 
methods to interfere with virus release, thus having therapeutic uses against virus 
infections (Welsch et al., 2007). All these considerations made the viral budding a perfect 
candidate for the present study. 
 
Thus, the main purpose of this work is to create a reconstituted model system(s) 
to study the mechanism of viral budding using matrix protein of NDV as a prototype 
budding agent. With this general purpose, the following specific objectives were 
established: 
• Purification of functional matrix protein from NDV 
o Obtaining matrix protein with high purity 
o Designing lipid membrane systems to characterize the membrane activity 
of the purified protein (e.g. binding and curvature creation) 
 
• Development of a model lipid system which allows reconstitution and real-time 
monitoring of domain-driven budding by the matrix protein 
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o Visualization of protein induced budding on giant unilamellar vesicles 
using bright-field and fluorescence microscopy 
o Characterization of budding dynamics by electrophysiological approaches 
on planar bilayer lipid membranes 
 
• Characterization of molecular mechanisms of budding 
o Study the influence of lipid composition 





An experiment is a question which science 
poses to Nature, and a measurement is the 






























2.1. APPARATUS AND MATERIALS 
Centrifuges: 
- J2-21 centrifuge (Beckman Coulter Inc., USA) 
  Rotors: JA-14 angular rotor 
- Optoma XL-100K ultracentrifuge (Beckman Coulter Inc., USA) 
 Rotors: SW-28 rotor, 50.2 Ti angular rotor and SW 55Ti (Beckman Coulter Inc., 
USA) 
- Eppendorf Centrifuge 5415D (Eppendorf, USA) 
- Bottles, tubes and vials appropriate for each type of rotor 
 
SDS-PAGE: 
- Novex® 4-20% Tris-Glycine precasted gels 1.5 mm X 10 well (InvitrogenTM 
Corp.,USA) 
- XCell SureLock™ Mini-Cell Electrophoresis System (InvitrogenTM Corp.,USA)  
- PowerPac™ Basic power supply (Bio-Rad Lab., USA) 
- FluorChem® FC system (Alpha Innotech Corp., USA) 
 
Protein concentration analysis 
- BCA™ protein assay kit (Pierce Biotechnology, Inc., USA)  
- SpectraMax 250 microplate reader (Molecular Devices Corp., USA) 
- Bio-Mini DNA/RNA/Protein analyzer (Shimadzu Scientific Instruments Inc., USA) 
 
LUV preparation: 
- Thermobarrel Extruder (Lipex Biomembrane Inc., Canada)  
- Polyester drain discs (Osmonic Inc., USA) 
- Polycarbonate 0.1 micron size filter (Osmonic Inc., USA) 
- Sephadex™ PD-10 columns (GE Healthcare Life Sciences, USA) 
- Superose™ 6 prep grade (GE Healthcare Life Sciences, USA) 
- 1.5x30 cm Econo-Column® Chromatography column (Bio-Rad Lab., USA) 







- Function generator GFG-3015 (Instek, USA) 
- 1 mm diameter platinum wire (Goodfellow Corp., USA) 
 
Microscopy: 
- 0.17 mm thick Delta T Dish (Bioptech Inc., USA) 
- Axiovert 200 Inverted microscope (Carl Zeiss, Inc., Germany): 
- 40x, 0.75 NA objective (ACHROPLAN; Carl Zeiss, Inc., Germany) 
- 150x, 1.45 NA objective (Olympus America Inc., USA) 
- CoolSNAP EZ camera (Photometrics, USA) 
- IPLab acquisition software (BioVision, Inc., USA) 
- IX-70 inverted microscope (Olympus America Inc., USA) 
- 150x, 1.45 NA objective (Olympus America Inc., USA).  
- Intensified charge-coupled device camera VE1000SIT (Dage-MTI, USA) 
- Metamorph Flashbus acquisition software (Molecular Devices Analytical Technologies, 
USA) 
- Tecnai G2 transmission electron microscope (FEI Company, USA) 
- 300 mesh carbon-coated gold EM grid (Electron Microscopy Sciences, USA) 
 
Protein thiol groups labeling 
- HiTrap™ desalting columns (GE Healthcare Life Sciences, USA) 
- Model 2110 fraction collector (Bio-Rad Lab., USA) 
   
Electrical admittance measurements: 
- Flaming Brown Micropipette puller; Model P80/PC (Sutter Instruments Co., USA) 
- 1.5 mm capillary borosilicate glass with filament (World Precision Instruments Inc., 
USA) 
- MicroFil™ syringe needle (World Precision Instruments Inc., USA) 
- Teflon® film (Fluoro-plastics, Inc., USA) 
- Red Sable brush #00 (Da Vinci brushes, USA) 
- Ag/AgCl pellet electrodes #EP05 (World Precision Instruments Inc., USA) 




- EPC 7 patch clamp amplifier (HEKA Instruments Inc., USA) 
- PC-44 acquisition board (Signalogic, USA) 
- Bronew adquisition software (Ratinov et al., 1998) 
 
Other apparatus and materials used: 
- Aminco-Bowman Series-2 luminescence spectrometer (Thermo Electron Corp., USA) 
- MicroTrough S (Kibron Inc., Finland) 
- 25 mL gradient mixer (Sigma-Aldrich Corp., USA) 
- Dynamax peristaltic Pump (Rainin Instrument, LLC, USA) 
- PC workstations (Dell Inc., USA) 
- Slide-A-Lyser® Dialysis Cassette; 10,000 mw; 3-12 mL (Pierce Biotechnology, Inc., 
USA) 
- Homemade and specially designed teflon chamber for monolayer formation and protein 
application 
- Rocker II orbital shaker (Boeker Scientific, USA) 
- Savant SpeedVac® Concentrator (Thermo Scientific, USA) 
- Stirrer/hot plate (Corning Inc., USA) 
- Vortex-genie 2 mixer (Scientific Industries Inc., USA) 
- PM 4600 Delta Range® scale (Mettler-Toledo, Inc.) 
- Balance (Sartorius AG, Germany) 
- Orion pH meter model 420A (Thermo Scientific, Inc, USA) 
- Safeaire fume hood (Fischer Hamilton, USA) 
- Vapor pressure osmometer 5500 model and calibration solutions (Wescor Inc., USA) 
- Freezers (-30 and -80) and fridge (4ºC) (Revco, Thermo Scientific, USA) 
- Argon, compressed gas (NIH supply service) 
- Nitrogen, compressed gas (NIH supply service) 







2.2. CHEMICALS AND LIPIDS 
 Lipids  
- Dioleoylphosphatidylcholine, DOPC (Avanti Polar Lipids, Inc., USA)  
-1-palmitoyl-2-oleoylphosphatidylcholine, POPC (Avanti Polar Lipids, Inc., USA) 
- Dioleoylphosphatidylethanolamine, DOPE (Avanti Polar Lipids, Inc., USA) 
-1,2-dioleoyl-phosphoglycerol, DOPG (Avanti Polar Lipids, Inc.,USA) 
- DOPE–lissamine Rhodamine B sulfonyl, Rh-DOPE (Avanti Polar Lipids, Inc., USA) 
- Cholesterol (Avanti Polar Lipids, Inc.,USA) 
- GM1 ganglioside conjugated with BODIPY-FL (InvitrogenTM Corp., USA) in the polar 




- 8-aminonaphthalene-1,3,6-trisulfonate, ANTS (Molecular Probes™ Invitrogen™ Corp., 
USA) 
- p-xylenebis(piridinium bromide), DPX (Molecular Probes™ Invitrogen™ Corp., USA)  
- 70 kDa Fluorescein isothiocyanate conjugated dextran, FITC-dextran (Sigma-Aldrich 
Inc., USA)  
- Uranyl Acetate (Electron Microscopy Sciences, USA) 
- Cy3 maleimide mono-reactive dye (GE Healthcare Life Sciences, USA) 
 
SDS-PAGE 
- Tris-Glycine SDS sample Buffer (2x) (InvitrogenTM Corp.,USA)  
- NuPAGE® Reducing Agent (10x) (InvitrogenTM Corp.,USA) 
- SeeBlue® Plus2 Prestained Standard (1x) (InvitrogenTM Corp.,USA) 
- Novex® Trys-Glycine SDS Running Buffer (10x) (InvitrogenTM Corp.,USA) 
- SimplyBlue™ SafeStain (InvitrogenTM Corp.,USA) 
- SYPRO® Ruby protein gel stain (InvitrogenTM Corp.,USA) 
  
Gradients components 
- Di-potassium tartrate hemihydrate (Fluka, Sigma-Aldrich Corp., USA) 




Buffers and buffer components 
- Tris-HCl 1 M solution pH 8.0 (KD Medical, Inc., USA) 
- Sodium chloride (NaCl) 5 M solution (KD Medical, Inc., USA) 
- Potassium Chloride, granular (KCl) (Mallinckrodt Baker Inc., USA) 
- EDTA 0.5 M solution (Quality Biological Inc., USA) 
- Calcium Chloride (CaCl2) 2M solution (Quality Biological Inc., USA) 
- Triton X-100 (Sigma-Aldrich Corp., USA) 
- Sucrose 99.5% GC (Sigma-Aldrich Corp., USA) 
- Hepes buffer 1 M solution (Cellgro® Mediatech, Inc, USA) 
- Phosphate buffer saline (PBS) buffer pH 7.4 (KD Medical, Inc., USA) 
 
Organic solvents 
- Chloroform 99.9% GC (Fluka, Sigma-Aldrich Corp., USA) 
- Decane 99.8% GC (Fluka, Sigma-Aldrich Corp., USA) 
- Octane 99.7% GC (Fluka, Sigma-Aldrich Corp., USA) 
- Squalane 99% (Supelco, Sigma-Aldrich Corp., USA) 
- Methanol 99.8% GC (Fluka, Sigma-Aldrich Corp., USA) 
- Ethyl Ether 99.9% GC (Fluka, Sigma-Aldrich Corp., USA) 
 
Other 
- α-chymotrypsin from bovine pancreas suitable for protein sequencing, salt-free, 
lyophilized powder  (Sigma-Aldrich Corp., USA) 
- Tris(2-carboxyethyl)-Phosphine Hydrochloride, TCEP HCl (Pierce)  
- Dimethylformamide (Sigma-Aldrich Corp., USA) 






2.3. BIOLOGICAL SAMPLES 
 Newcastle Disease Virus Clone-30 strain was obtained from Intervet Laboratories 
S.A. (Salamanca, Spain). Newcastle Disease Virus LaSota strain was obtained from 
Charles Rivers Laboratories Inc., Massachusets, USA. The virus was grown in the 
allantoic cavity of 11 old day pathogen-free chick embryos (CBT Farm, Chestertown, 
MD). Upon infection, embryos were grown for 48 hours at 37ºC and 55% humidity. The 




2.4. ANALITICAL SOFTWARE 
- Origin 7.0 (OriginLab Corp., USA) for data presentation and analysis 
- MetaMorph (Molecular Devices Analytical Technologies, USA) for image analysis 
- ImageJ NIH software for image analysis 
- Maple Software (Maplesoft, Canada) for theoretical modelling 






2.5.1. Virus and matrix protein purification 
 
 NDV of LaSota or clone-30 strains was purified as described previously (Garcia-
Sastre et al., 1989). The virus was separated from the rest of the allantoic fluid by two 
hours centrifugation of ∼500 mL of allantoic fluid at 12,000 rpm using angular rotor JA-
14 (J2-21 centrifuge). The pellet was then soaked with 12 mL of 10mM Tris-HCl, 
100mM NaCl and 1 mM of EDTA buffer at pH 7.4 (buffer 1) for 12 hours at 4ºC and the 
virus aggregate was resuspended by vigorous mixing. Six gradients of 10-50% (w/v) di-
potassium tartrate were prepared by continuous gradient mixing of 17 mL of 10% 
solution and 17 mL of 50% solution of tartrate (both solutions were prepared by 
dissolving the appropriate amount of dipotassium tartrate in buffer 1). 2 mL of the sample 
containing resuspended virus were placed on top of the gradients and the purification was 
performed by overnight gradient centrifugation at 21,000 rpm with SW 28 rotor at 4ºC. A 
cushion containing the virus formed in the middle of the tartrate gradient. This cushion 
was carefully sucked with a sterile insulin syringe. To concentrate the purified virus the 
recovered sample was centrifuged for 1.5 hours at 34,800 rpm using a 50.2 Ti angular 
rotor (Optoma ultracentrifuge). The supernatant was discarded.   
 The Scheid and Choppin’s purification protocol was used as a reference for M 
protein purification (Scheid and Choppin, 1973). Basic steps in this purification are 
outlined in Figure 9. To separate the lipid anchored proteins from the viral nucleocapsid, 
the virus pellet was resuspended into 10 mL of 1 M KCl, 10 mM Tris-HCl and 5 mM 
CaCl2 containing buffer at pH 7.4 (buffer 2) with 2% the of detergent Triton X-100 and 
incubated 30 minutes at room temperature with constant agitation. After incubation, the 
sample was again centrifuged at 43,850 rpm during 2 hours at 4ºC using the SW 55Ti 
rotor. This time, the supernatant containing M, HN and F protein and viral lipids was 
recovered and dialyzed against 2 L of buffer 2 without KCl  (with 5 changes) during 36 
hours. This led to M protein precipitation and separation from the rest of the viral 
membrane proteins. The contents of the dialysis bag were centrifuged using the SW-28 
rotor at 7,000 rpm, 30 minutes at 4ºC. The M protein pellet was dissolved in 1 mL of 20 





Figure 9. Squematic representation of NDV matrix protein purification based on its aggregation at low 
ionic strength. 
 Protein concentration was determined by the spectroscopic procedure of 
Markwell and co-authors (Markwell et al., 1978), or with the BCA™ protein assay kit 
(Pierce, IL, USA), using a SpectraMax 250 microplate reader, with BSA solutions of 
known concentration as standards.  
 
 
2.5.2. SDS-polyacrylamide gel electrophoresis, gel staining and analysis 
 
All protein analysis by SDS-PAGE was carried out using the Novex® Pre-Cast Gel 
electrophoresis system from InvitrogenTM. Protein or LUV-protein samples were mixed 




(10x), to a final volume not larger than 35 µL. The sample vials were incubated in a 
water bath at 80ºC for 5 minutes to denature the protein samples. The samples were 
loaded into Novex® 4-20% Tris-Glycine precast gels (1.5 mm X 10 well) together with 
SeeBlue® Plus2 Prestained Standard (InvitrogenTM). The electrophoresis was conducted 
at room temperature using Novex® Trys-Glycine SDS Running Buffer in the XCell 
SureLock™ Mini-Cell Electrophoresis System (InvitrogenTM) connected to a power 
supply. Gels were run at a constant voltage of 120 V for 120 minutes.  
After electrophoresis, gels were stained ether with SimplyBlue™ SafeStain or 
SYPRO® Ruby protein gel stain following the product’s instructions. Stained gels were 
transilluminated with white or ultraviolet light for imaging of SimplyBlue™ or SYPRO® 
Ruby gel stains, respectively, and gels images were taken using the FluorChem® FC 
system. Gel background subtraction and initial gels images analysis were performed 
using the Alpha Ease® FC program. The data corresponding to the area under the 




2.5.3. Preparation of large unilamellar vesicles  
 
Large unilamellar vesicles (LUVs) were prepared by an extrusion procedure (Mayer 
et al., 1986) from the lipid mixtures listed in Table 4. Solutions of the lipid mixtures in 
chloroform were dried under an argon stream followed by 2 hours of incubation under 
high vacuum to remove traces of chloroform. Dry lipid films were then hydrated in an 
appropriate volume of working buffer (100 mM KCl, 20 mM Hepes and 0.2 mM EDTA, 
pH 7.4) or one of the liquid dye containing buffers (12.5 mM ANTS, 45 mM DPX, 20 
mM KCl, 0.2 mM EDTA, 20 mM HEPES, pH 7.4 or 75 mg/ml 70 kDa FITC-dextran 
dissolved in working buffer) and dispersed by vortexing to obtain multilamellar vesicles 
(MLV). Lipid hydration and equal transmembrane solute distribution were promoted by 
10 cycles of freezing in liquid nitrogen and thawing of the MLV dispersion. Then, the 
MLV dispersion was loaded into the extruder (Figure 10) preassembled with a drain disc 
and a polycarbonate 0.1 micron size filter. Following introduction of the sample, the 




the outlet tubing. The extrusion process was repeated for a total of 10 passes. Un-
encapsulated ANTS/DPX was separated from LUVs using prepacked Sephadex™ PD-10 
columns. Untrapped 70 kDa FITC-dextran was removed using a Superose™ 6 packed 
column at a 1 mL/min flow rate. In both cases, working buffer was used as the elution 
buffer. The osmolality of all solutions used was measured using a vapor pressure 
osmometer (Wescor 5500, Logan, UT) and equilibrated accordantly. LUV preparations 
that were employed in experiments showed unimodal size distributions as determined by 
dynamic light scattering measurements. Mean diameters of LUV preparations were 
estimated to be 120±30 nm. 
 





Figure 10. Thermobarrel extruder from Lipex biomembrane Inc., USA. The MLV dispersion was loaded 
into the extruder preassembled with a drain disc and a polycarbonate 0.1 micron size filter. Following 
introduction of the sample, the extruder was pressurized with nitrogen gas and the extruded sample was 
recovered form the outlet tubing. 
 
 
2.5.4. Analysis of matrix protein binding to large unilamellar vesicles 
 
The amount of LUV in the LUV dispersion was normalized to the total fluorescence 
signal of Rh-DOPE (incorporated into LUV membrane composition) after infinite 
dilution with 0.1% Triton X-100. M protein (5 µM) was incubated for 5 min with LUVs 
of different lipid compositions or at different protein/lipid ratios. The protein bound to 
LUVs was separated from the unbound protein fraction using the Ficoll™ gradient 
flotation method (Fraley et al., 1980). A non-continuous Ficoll™ gradient was prepared 
in polycarbonate centrifuge tubes (Figure 11). The lower layer of the gradient contained 
pre-incubated LUV-protein sample that was mixed with 50% Ficoll™ (w/v) dissolved in 
the working buffer. The final Ficoll™ concentration of the first gradient layer was 20%. 
The following layer contained 10% Ficoll™ dissolved in working buffer. The last layer 
had working buffer without Ficoll™. The gradient was centrifuged using a swinging 
bucket rotor (SW 55Ti) at 4ºC and 45,000 rpm for 30 minutes. Following centrifugation, 
the bound fraction of M was recovered together with the rhodamine labeled band of 
LUVs floating in the buffer-10% Ficoll layer boundary. The samples were than re-
normalized against the rhodamine fluorescence signal and diluted to have the same 




samples were analyzed using SDS-PAGE. After electrophoresis, gels were stained with 
SYPRO® Ruby protein gel stain and scanned with FluorChem FC Imaging System. 
 
Figure 11. M protein-LUV co-flotation gradient centrifugation assay. A non-continuous Ficoll®  gradient 
was prepared in a polycarbonate centrifuge tube. The lower layer of the gradient contained pre-incubated 
LUV-M protein sample and 20% (w/v) Ficoll® dissolved in working buffer. The following layer contained 
10% Ficoll  in buffer and the last layer had only working buffer. The gradient was centrifuged using a 
swinging bucket rotor during 30 minutes. Following centrifugation, the bound fraction of M was 
recuperated in the buffer-10% Ficoll layers boundary. 
 
 
2.5.5. Matrix protein interaction with large unilamellar vesicles: fluorescence 
measurements 
 
Leakage of ANTS or FITC-dextran and changes in fluorescence intensity of Rh-
DOPE or BODIPY-GM1 (in quenched or non-quenched concentration) after addition of 
the protein sample (M protein, BSA or M protein digested 5 minutes with α-
chymotrypsin (1:5 molar %)) to LUVs were determined at ambient temperature and under 
constant stirring by spectrofluorimetric measurements using a luminescence spectrometer. 
The normalized fluorescence intensity FN was recalculated from the integral LUV 








FFF   (3) 
where Fi corresponds to the fluorescence intensity before the protein addition and Ff  to 
the fluorescence intensity after complete disruption of LUV (infinite dilution of the 
fluorophores) by detergent (0.1% of Triton X-100). The excitation/emission wavelengths 




for Rh-DOPE, 505/525 nm for BODIPY-GM1, and 490/520 nm for FITC-dextran. Data 
analysis was performed using Origin 7.0 software. 
 
 
2.5.6. Preparation of giant unilamellar vesicles 
  
 The lipid mixtures used for GUV preparation are listed in Table 5. Giant 
unilamellar vesicles were prepared using a slight modification of the electroformation 
protocol (Angelova and Dimitrov, 1988). When the lipid mixture contained the charged 
lipid DOPG, the mixture was dissolved in chloroform:methanol:ethyl ether (4:1:5 volume 
ratio), to a final concentration 0.1 g/L (total lipid/solvent). In all other cases, the mixtures 
were dissolved in chloroform:methanol (9:1 volume ratio), to a final concentration 0.1 
g/L . Two drops of 1 µL of the lipid solution were deposited on two platinum electrodes. 
The electrodes were dried under vacuum for at least 1 hour or overnight and then 
assembled on a microscopy dish with a 0.17 mm thick cover glass bottom. The dish was 
mounted on a stage of an inverted microscope and electrodes were then connected to the 
voltage generator, which applied a sinewave of 10 Hz frequency. The initial amplitude of 
the sinewave was 0.2 V. Right after the voltage application a buffer containing 20 mM 
Hepes and approximately 200 mM sucrose at pH 7.4 (osmotically equilibrated with 
working buffer) was added to cover the electrodes. During the following 15 minutes, the 
sinewave amplitude was gradually increased from 0.2 to 1.0 V. Electroformation times 
varied from 15 minutes to 1 hour for different lipid compositions of the GUV. After 
GUVs became visible on the electrode by microscopic observation, the voltage was 
lowered to 0.2V and then turned off completely. GUVs were either detached from the 
electrodes (by lowering the frequency to 0.1 Hz before lowering of the voltage) and 






Table 5. GUV lipid composition. 
 
 
2.5.7. Fluorescence microscopy observations of the interaction of matrix protein 
with giant unilamellar vesicles 
 
Visualization of GUVs attached to the electrode was performed on an inverted 
microscope (Axiovert 200; Carl Zeiss, Inc.) using a 40x, 0.75 NA objective 
(ACHROPLAN; Carl Zeiss, Inc.). GUVs detached from the electrode were settled on the 
bottom of a 0.17mm-thin glass dish (diameter 35 mm) pretreated with 1 g/L BSA for 1 
min and thoroughly washed with the working buffer to reduce GUV shrinking on the 
glass. The interaction of M protein with GUVs detached from the electrode was recorded 
using Axiovert 200 or Olympus IX-70 inverted microscopes both equipped with 150x, 
1.45 NA objectives (Olympus). The images were digitized using a CoolSNAP EZ 
(Photometrics) or an intensified charge-coupled device camera (VE1000SIT; Dage-MTI) 
using IPLab (BioVision) or Metamorph Flashbus (MDS Analytical Technologies) 
acquisition software, respectively. The pipettes for M protein application were obtained 
by pulling a 1.5 mm capillary borosilicate glass with a micropipette puller. The pipette 
was back-filled with M protein solution using a 1 mL syringe equipped with MicroFil™ 
(WPI, Inc). GUV fluorescence intensity analysis was performed with MetaMorph 




2.5.8. Cy3 maleimide staining of matrix protein 
 
The staining of matrix protein was performed using Cy3 maleimide mono-reactive 
dye from Amersham Bioscience following the protocol recommended for the labelling of 
IgG antibody. Briefly, the protein was diluted to 1 g/L using degassed working buffer. A 
100 molar excess of TCEP was added, and, after flushing the vial with nitrogen gas, the 
vial was closed and mixed thoroughly. The reaction was conducted at room temperature 
for 10 minutes. Then 50 µL of the dye dissolved in dimethylformamide was added to the 
reduced protein solution. The vial was again flushed with nitrogen and mixed thoroughly. 
The reaction was conducted at room temperature for two hours with mixing every 30 
minutes and left overnight at 4ºC. The separation of the protein from free dye was done 
using a pre-packed HiTrap™ desalting column (GE Healthcare) attached to the peristaltic 
pump and a fraction collector. The dye/protein ratio of the protein eluted from the column 
was estimated by absorbance measurements with a Bio-Mini DNA/RNA/Protein analyzer 
(Shimadzu), using extinction coefficients of 150,000 M-1cm-1 at 552 nm for Cy3 and 
30,000 M-1cm-1 at 280 nm for matrix protein, and taking into account that the dye 
contributes to the absorbance at 280 nm which is about 8% of its absorbance at 552 nm. 













dyeCy   (4) 
 
 While this measurement indicates that about 4 dye molecules are conjugated to 
each protein, the expected fluorescence signal is hard to estimate due to the possibility of 
quenching of the dye fluorophores located on the protein.  
 
 
2.5.9. Detection of vesicle budding/fission by admittance measurements 
 
Planar bilayer lipid membranes (BLM) were formed by the Mueller-Rudin 
technique (Mueller and Rudin, 1967) from a lipid solution in squalane. The lipid mixture 
was prepared from stock solutions of DOPC:DOPE (2:1 molar %) and 20 molar % 




volume) and squalane or a decane:octane mixture (1:1 v/v) were added to reach a final 
concentration of 20 mg of lipids per 1 mL of solvent.   
 
BLM was formed on an aperture of a horizontal Teflon film (thickness 40 µm), 
separating upper and lower compartment of a special chamber (Figure 12). Apertures of 
100–200 µm in diameter were punctured by an injection needle. The aperture was 
pretreated with 5 µL of the lipid solution in decane/octane (1:1) and left in vacuum for 
~30 minutes to let the solvents evaporate. Then the chamber was filled with electrolyte 
(working buffer) and mounted on the stage of an inverted microscope (Olympus IX-70); 
the orifice was visualized by phase-contrast microscopy using a 40X objective. BLM was 
formed up by the “painting” technique: a small amount of the lipid solutions in squalane 
was picked by a sable brush and deposited across the orifice so that a thick film covering 
the orifice was formed. If necessary, the excess of the solution was removed by a clean 
brush. The film then thinned spontaneously as seen by the formation of a clean round 
area in the phase-contrast image and an increase in the electrical capacitance of the film. 
To monitor electrical parameters of the film, Ag/AgCl pellet electrodes were immersed 
into both compartments of the chamber. The upper electrode was inside a standard patch-
clamp pipette (see below), while the lower electrode was immersed directly into the 
lower compartment (Figure 12A). An EPC 7 patch clamp amplifier (HEKA) and PC-44 
acquisition board with on-board software lock-in (Bronew software (Ratinov et al., 
1998), available upon request) were used to apply voltage and record electrical current 
from the BLM. The specific capacitance of thin films was estimated to be 0.9–1.0 
µF/cm2, corresponding well to the values characteristic for bimolecular lipid films 
published elsewhere (Melikov et al., 2001).  
BLM was patch-clamped by a pipette (Lollike and Lindau, 1999) containing M 
protein (0.2 µM, estimated ~0.05 molar protein/lipid ratio or 5 µM). 1–3 MOhm Sylgard-
coated borosilicate glass pipettes filled with working buffer were used. The pipettes were 
brought to the BLM using precise piezo micromanipulators. After formation of a tight 
giga-seal (Neher and Sakmann, 1992) contact between the pipette and BLM (Figure 
12B), a 5000 Hz, 100 mV sine-wave potential superimposed with a 20 mV constant 
holding potential Vhold was applied. The resulting current was decomposed by the Bronew 




(AC), sin phase and 90o-shifted with respect to the applied voltage; the phase correction 
was performed by dithering the C-fast compensation circuit of the EPC-7 amplifier as 
described elsewhere (Neher and Sakmann, 1992)). Data were stored on the hard drive of 
a PC computer and analyzed off-line. 
 
 
Figure 12. Experimental setup for electrical admittance measurements. A. BLM is "painted" on a hole in 
the Teflon film partition. To monitor electrical parameters of the membrane film, Ag/AgCl pellet electrode 
is immersed into the lower compartment of a teflon chamber and the upper electrode is inserted inside a 
standard patch-clamp pipette containing the protein solution. B. After the pipette enters in contact with the 
membrane by its piezo manipulation, a giga-seal is established between the patch area (represented in red) 
and the pipette tip, allowing for patch capacitance monitoring. 
 
Generally, changes in the direct current (DC) indicate formation of conductive 
pathways (such as channels or pores) allowing for direct translocation of ions across the 
BLM patch inside the pipette. Changes in the amplitudes of the two components of the 
alternate current (AC) are proportional to the real (∆Re) and imaginary (∆Im) parts of the 
electrical admittance of the patch (Frolov et al., 2003). Besides formation of pores and 
channels, these changes also report total electrical capacitance and geometry of the patch. 
The capacitance of the patch may be further analyzed in terms of the bud area as: 
0*CAC budbud =   (5) 
where C bud is the capacitance of the bud at the maximum value of ∆Im, Abud is the total 
area of the bud and C0 is the specific capacitance of the membrane. 
A flat unperturbed membrane patch (e.g. as in control experiments where no proteins 




circuit in Figure 23b) and its DC conductance (GDC) is negligible. Thus, at the reference 
state, the DC signal through the patch is at a background (zero) level (Gdc=Idc/Vhold), and 
so is the real part of the admittance (Re). The imaginary part of the admittance, ∆Im, is 
proportional to the total electrical capacitance of the patch: Im=αCpatch, where α is the 
proportionality factor. Thus, the Im channel is calibrated using the Cfast compensation 
circuit of the EPC-7 amplifier, so that α is found and further used for the analysis of 
admittance changes. To increase the dynamic range and signal-to-noise ratio of the 
measurements, the initial capacitance of the patch is then compensated, so that only 
changes in amplitudes of Re and Im components of the AC current (∆Re and ∆Im) are 
recorded.  
Recordings were started after the calibration and compensation procedures are 
finished: typically ~ 1min after establishment of the giga-seal contact between the patch-
pipette and BLM.  
∆Re and ∆Im were analyzed off-line (assuming the formation of a bud with 
capacitance Cbud connected to the reservoir membrane by a neck with conductance Gn) 



























ω ;  (7) 
 
where ω=2πf, and f is the sine wave frequency. In general, the capacitance of the bud 
membrane Cbud and Gn were calculated offline according to the formulae (easily obtained 



















2.5.10. Analysis of matrix protein condensation on lipid monolayers 
 
The specially designed teflon chamber was used (Ford et al., 2001) as shown  in 
Figure 13.  2 µL DOPC:cholesterol (9:1 molar %, 0.1 g/L final concentration) lipid 
solution in methanol/chloroform (9:1) was deposited on the working buffer-air interface 
(the buffer volume in the chamber was about 400 µL) to form a lipid monolayer. After 
one hour equilibration, a carbon-coated gold EM grid was placed on top of the buffer 
droplet where the lipid monolayer had been formed. 0.13 µg of M protein was applied to 
the buffer from a side opening using a hamilton syringe. After 1 hour incubation the grid 
was carefully removed and stained with uranyl acetate (2% solution in water) for further 
observations with Tecnai G2 transmission electron microscope (FEI Company) at 120 
kV. 
 
Figure 13. Assay for M protein condensation on lipid monolayer. First the lipid monolayer is deposited 
on the buffer droplet. After the monolayer has stabilized, EM grid is applied on top. Protein is injected form 
the side orifice using a Hamilton syringe. After a period of incubation, the grid is removed and negatively 
stained before the TEM analysis. 
 
2.5.11. Preparation of lipid monolayers  
MicroTrough S (Kibron Inc., Finland) apparatus was used to study the lipid, 
protein or lipid-protein monolayer properties (Figure 14). For preparation of a lipid 
monolayer, 10 µL of a hexane solution of DOPC:Cholesterol (9:1 molar %, 0.5 g/l) was 
spread on the surface of the working buffer. After 20 minutes, the monolayer was slowly 




FilmWare 2.41 Kibron software. The same procedure was performed to study the M 
protein formed films, where 10 µL of M protein diluted in the working buffer (final 
concentration 0.6 g/L) was deposited on the buffer-air interface. In the case of M protein 
interaction with the lipid monolayer, the lipid monolayer was first pre-formed and 
compressed to ∼ 2 mN/m.  MicroTrough S system allowed displacing the barriers so that 
the compressed lipid monolayer was on one side of the trough and the protein could be 
applied from the other side. After the pre-compression, the lipid monolayer was slowly 
moved toward the zone where the protein was applied. The resulting protein-lipid 
monolayer was stabilized during 20 minutes and then compressed to obtain the surface 
pressure-area isotherm, which was then plotted and analyzed using Origin 7.0 software. 
 
Figure 14. Photograph of MicroTroughX apparatus (Kibron Inc.). While the barriers are in their extreme 
positions, the trough is filled with the subphase (working buffer) and the desired film is applied on top of 
the subphase. After the monolayer stabilization, the barriers are compressed and the surface pressure-area 
isotherm is measured by Wilhelmy method as the force due to surface tension on the suspended wire is 
measured by a microbalance.  
 
 
There are three principal means of acquiring knowledge 
available to us: observation of nature, reflection, and 
experimentation. Observation collects facts; reflection 
combines them; experimentation verifies the result of that 
combination. Our observation of nature must be diligent, 
















3.1. Purification of matrix protein from Newcastle Disease Virus: effect of calcium
 
Various viral matrix proteins are known for their ability to self-assemble into 
ordered structures in low salt solutions. The speed and efficiency of such aggregations are 
usually determined by ionic strength and protein concentration (McCreedy et al., 1990).  
This sensitivity has been routinely used to separate matrix protein from the rest of the 
viral proteins: M protein appears mostly as a monomer at high ionic strength, but 
aggregates slowly and irreversibly at physiological ionic strength (Sagrera et al., 1998). 
Accordingly, the use of high ionic strength (>1M) solution during purification is critical 
for disassembly of the interior of NDV. However, some experimental observations 
indicate that M protein interaction with NP protein is not totally disrupted during the 
purification procedure based on salt concentration changes, and that the aggregation of M 
protein may be in part due to the formation of this M-NP complexes. At the initial state of 
this work it was found that calcium at milimolar concentration allows a better separation 
of M protein from the NP complex, presumably through disruption of some electrostatic 
interactions (Figure 15A).  
 
Figure 15. M protein purification and analysis of the protein purity by SDS-PAGE. A. Comparison of the 
final products of the M protein purification procedure conducted with (5 and 1 mM Ca++, right lane) and 
without calcium (left lane). The addition of millimolar calcium to the buffers during the protein purification 
augmented disruption of the M-NP protein complex. B. Analysis of the purity of M protein purified in the 
presence of Ca++. The first lane of the gel shows molecular weight standards; 0.2, 0.5, 1, 1.5, 2, 3 and 5 µg 
of M protein were loaded into lanes 2 to 8, respectively. The gel was stained with SimplyBlueTM 
(Invitrogen), scanned, and the densitometry analysis of the protein bands in each lane was performed in 
accordance with the procedure developed earlier (Materials and Methods). C. The graph shows the 
dependence of the area under the peak attributed to the M protein band (without impurities) on the total 
amount of M protein loaded in the lane; red line is the linear extrapolation calculated on the first four points 
corresponding to non-saturated M protein loads. The confidence intervals (95%) of this extrapolation are 




 This modified protocol allowed obtaining highly purified M protein. The protein 
purity was estimated from SDS-PAGE gel (Figure 15C) according to a procedure based 
on analysis of the areas under the intensity peaks (corresponding to protein bands) 
(Coorssen et al., 2002). The intensity curves in Table 6 correspond to the individual lanes 
in the gel showed in Figure 15B. Graphic representation of the peak area values versus 
the amount of protein loaded in the lane demonstrates a non-linear dependence (Figure 
15C). However, the first four point of the curve can be linearly fitted (red line in Figure 
15C, r=0.985). Extrapolating the line defined by the fitting parameters over the last points 
of the curve, the expected peak intensity for the 5 µg of pure protein is obtained. Then, 











Purity              (10) 
where A denotes the area under the intensity peaks.  A purity of 94±2% (at 95% 
confidence interval (Coorssen et al., 2002)) was obtained.  
 






3.2. Matrix protein associates with and deforms large unilamellar vesicles 
 
The characterization of M protein binding to large unilamellar vesicles (LUV) of 
different lipid compositions was performed to define the membrane composition 
preferences of M protein from NDV LaSota strain.  
The co-flotation assay (see Material and Methods) was chosen to monitor 
irreversible binding of the protein to LUVs. This assay showed tight binding of M protein 
that is dependent on the lipid composition of the membrane and on the protein 
concentration (Figure 16A and B, respectively). In addition, M protein showed a higher 
affinity to LUVs whose composition contained cholesterol, or PE and cholesterol (as can 
be observed in Figure 16A). Presence of negatively charged lipids in the LUV membrane 
composition did not improve the binding of the protein, thus indicating the hydrophobic 
character of M protein-membrane association apparently is mediated by  the protein 
insertion into the lipid bilayer. This result is in a good agreement with the previously 
reported study of M protein from another NDV strain (Australia-Victoria), where the 
interaction of the protein with multilamellar liposomes was also shown to be non-
electrostatic (Faaberg and Peeples, 1988). The membrane composition to which the 
protein showed the highest affinity was chosen to perform all subsequent protein-
membrane interaction studies. If not indicated otherwise, the default lipid composition for 
the different lipid systems used is DOPC:DOPE:Cholesterol in variable molar ratios. 
The vesicle stability upon M protein adsorption was explored using LUVs loaded 
with aqueous fluorescent markers, either small (ANTS/DPX) or large (70 kDa FITC-
dextran). Starting at ~0.01 protein/lipid ratio, release of both markers was seen with 
slower kinetics for the larger marker (Figure 16C, blue and green squares). The 
possibility that the observed effects of the protein were caused by some artifact present in 
the protein solution (for example, the detergent triton that was used during the protein 
purification) was checked by α-chymotrypsin proteolytic treatment of the protein (Figure 
16D). After this treatment, the efficiency of content release from LUV after protein 






Figure 16. Characterization of M protein interaction with large unilamellar vesicles. A. M protein 
adsorption on LUV of different lipid composition (0.005 protein/lipid ratio) measured by gradient flotation 
technique; protein was loaded in the same concentration in all bands; control fraction (M, no lipids) was 
taken at the same level as the liposome fraction. B. M protein adsorption on PC:PE:Chol LUV at different 
protein/lipid ratio measured by liposome co-flotation assay (see Material and Methods); the same protein 
concentration for all bands was loaded; control fraction (M, no lipids) was taken at the same level as the 
liposome fraction; positive control shows known M protein sample loaded in the band. C. Sequential 
additions of 0.3 µM of M protein induce release of LUV entrapped ANTS/DPX (blue squares) or 70-kDa 
FITC conjugated dextrans (green squares) seen as changes of normalized fluorescence intensity (Material 
and Methods). Addition of the same amount of the protein cleaved by α-chimotrypsin caused minor release 
of ANTS/DPX and dextrans (blue and green triangles); bars show SD. D. Proteolitic treatment of M 
protein. The protein (5 mM) was incubated for 5 minutes at room temperature with the amount of α-
chymotrypsin indicated in the gel picture; the reaction was stopped by addition of SDS sample buffer and 
the resulting material was analyzed by SDS polyacrylamide electrophoresis. The first lane shows molecular 
weight standards. 
 
Release efficiencies were comparable for both high and low molecular weight 
markers for the same amount of the protein added, thus indicating vesicle bursting. In 
corroboration of this notion, the extent of content release grew almost linearly, as it does 
in experiments on the osmotic rupturing of LUV (Mui et al., 1993) (Figure 17A). 
Additionally, formation of pores by M proteins was excluded by electrophysiological 
measurements (see below). Consequently, the most likely cause of LUV bursting was 
membrane deformation. M protein induced LUV content release at relatively high surface 
coverage (estimated as one M protein per ~8 lipids in the outer monolayer). At this 




inward (Figure 17B) as VSV matrix proteins do (Solon et al., 2005). Most deformations 
of a quasispherical LUV increase its surface/volume ratio, thus attempting to stretch the 
liposome membrane. Accordingly, the inward bending would tend to stretch the LUV 
membrane (Figure 17C; (S1+S2)>S) leading to its rupture if the M protein cap covers 
enough LUV area (10 % of the LUV area should be covered by the protein (see appendix 
I), comparable with estimates from experimental data). 
 
Figure 17. Rupture of large unilamellar vesicles by M protein induced membrane stress. A. Osmotic 
pressure induces carboxifluorescein release from LUV (Mui et al., 1993). B. Schematic representation of M 
protein oligomerization causing invagination of the membrane of spherical LUV. It is assumed that M 
proteins bring negative curvature characteristic for the NDV membrane (~ -0.3 µm-1), while the LUV 
radius is assumed to be 0.1 µm. C. M protein-induced invaginations result in an increase of the LUV 
membrane area, if the LUV volume (V) is maintained constant (see Appendix  I). The membrane area can 
increase only in ~3% before rupturing27. In appendix I it is discussed how 3% of LUV area increase 




Until the protein/lipid ratio of ~0.01, no release of LUV contents was detected 
(Figure 16C). Yet, M protein bound to LUVs even at lower protein to lipid ratios (Figure 
16B), indicating that a critical amount of M protein on a liposome surface was needed to 
initiate the content release. The binding threshold before the effect of the protein on LUV 
may be an indication of the two-dimensional self-assembly of M protein on the 
membrane surface. These results, together with the M protein capacity to aggregate in 
solution (upon lowering of ionic strength (Sagrera et al., 1998)) and its tight lining of the 
virus membrane (Faaberg and Peeples, 1988), are apparently in agreement with the 
hypothesis of M protein self-assembly on the membrane surface into a domain, likely 
stabilized by electrostatic interactions.  
To further investigate the origin of M protein-membrane interaction, LUVs were 
loaded with rhodamine-DOPE or another membrane probe, BODIPY-GM1 in self-
quenched concentration. Both types of membrane markers showed similar fluorescence 
increase (dequenching) upon M protein addition. In contrast, addition of another 
membrane active protein, BSA, to the same LUVs resulted in a slight decrease of the 
fluorescence (Figure 18A). M protein caused no effect on the fluorescence of LUVs 
containing non-quenched dyes (Figure 18A). Though the exact mechanism of 
dequenching of membrane fluorescence by M protein had not been resolved, similar 
behavior of different fluorophores precluded specific interactions between the 
fluorophore and the protein. More likely, the fluorescence increase corresponds to general 
constraints of lipid mobility known to be imposed by membrane-associating M proteins 
(Neitchev and Dumanova, 1992). Confirming this hypothesis, the increase of steady-state 
anisotropy of BODIPY-GM1 fluorescence (reporting the probe mobility (Marushchak et al., 
2006)) upon M protein addition was detected for the self-quenched and non-quenched dye 
(Figure 18B). Again, a likely explanation of this phenomenon is protein self-assembly 
into a domain on the lipid membrane surface. 
To summarize, experiments with LUV resulted in initial characterization of the M 
protein-lipid interactions (including quantification of binding) and suggested formation of 
membrane domains by M proteins. To visualize M protein activity and check the validity 






Figure 18. M protein adsorption induces changes in fluorescence of lipid probes incorporated into LUV. 
A. Sequential additions of 0.3 µM of M protein or BSA to LUV cause dequenching of Rh-DOPE or 
BODIPY-GM1 fluorescence (red and black circles); no changes were detected for non-quenched dyes (red 
and black open diamonds) or when BSA was added (dark yellow circles). B. Measurements of the 
anisotropy of the BODIPY-GM1 fluorescence. Anisotropy of the fluorescence of BODIPY-GM1 incorporated 
in LUV was measured as described earlier (see Material and Methods). LUV contained either 2 molar % 
(self-quenched) or 0.2 molar% (non-selfquenched) of the probe. The anisotropy spectra were collected 
before (dark and light green) and 10 minutes after (red and dark green) the M protein addition in final 
concentration of 2 µM. For both, quenched and non-quenched dye, the anisotropy curve raised indicating 
decreased mobility of the fluorophores. 
 
 
3.3. Matrix protein induces budding upon adsorption on giant unilamellar vesicles: 
fluorescence microscopy observations 
 
Giant unilamellar vesicles (GUV) containing fluorescently labeled lipid 
(rhodamine-DOPE) in self-quenched concentration were used to visualize the interaction 
of M protein with lipid membranes by fluorescence microscopy. In the first round of 
experiments, a small patch of GUV membrane was isolated inside a pipette containing M 
protein. Shortly after establishing a stable contact between the GUV membrane and the 
pipette containing 2 µM M protein solution, the fluorescence intensity of the membrane 
patch inside the pipette increased sharply (Figure 19A, second frame expanded with false-
color in Figure 19B). The following membrane rearrangements resulted in the budding of 
round vesicles of different diameters visible near the patch. The membrane outside the 
patched area provided a lipid reservoir to support this small vesicle formation from the 




diameter decreases progressively: thus the contact with the pipette did not interfere with 
lipid exchange between the mother membrane and the isolated membrane patch. Finally 
the GUV membrane detached from the pipette and multiple vesicles were seen moving 
inside the GUV (Figure 19A, see also movie1 in appendix II).  
 
Figure 19. Interaction of M protein with a membrane patch of the GUV isolated by a patch-pipette. A. 
Frame sequence (time in seconds) illustrating membrane budding from a patch-pipette (approximately 
drawn in the first image) containing M protein (2 µM). A small part of the large GUV, attached to platinum 
electrode used for electroformation, was sucked into the pipette. The recording  began shortly after the 
establishment of a stable contact between GUV and the pipette; bar 5 µm. B. Expanded images, showing 
the area marked by the blue rectangle in A, illustrating the brightening of the membrane patch upon M 
protein adsorption. 
In a second set of experiments, the pipette containing a concentrated solution of 
the protein (4 µM) was placed near the GUV. The protein was applied by a pulse of 
positive hydrostatic pressure so that the protein concentration in the GUV vicinity 
increased transiently. Shortly after protein application, formation of bright spots within 
the original GUV contour was observed (Figure 20A, movie2 in appendix II). Appearance 
of the spots corresponded to a sharp increase in the average fluorescence intensity 
calculated in the GUV projection area (Figure 20B). These brightened areas were 




was applied, the deformations gradually disappeared while the protein concentration 
decreased as the proteins diffused away from GUV. Finally, the GUV relaxed to its 
original spherical shape (movie 2 in appendix II). This shape relaxation coincided with a 
decrease in the fluorescence of the GUV membrane to a new steady-state level (Figure 
20B, I2). Both shape and fluorescence changes could be initiated again by application of 
more M protein until the GUV was completely destabilized. After each protein 
application the apparent size of the GUV decreased and the steady-state fluorescence of 
the GUV projection area increased (Figure 20B, from I1 to I2). Internalized membrane 
vesicles were clearly detected, thus justifying this fluorescence changes (Figure 20A, see 
also Figure 22 with different lipid composition). 
 
Figure 20. Interaction of M protein with GUV: membrane domains and deformations. A. Changes of 
membrane fluorescence followed by membrane deformations induced by a transient application of M 
protein (added at t=0) to a GUV made of PC:PE:Chol mixture; white arrows show joining of bright 
membrane domains; B. Analysis of fluorescence intensity changes in the time sequence from A. C. Bright 
spots appear and merge after M protein application to a GUV flattened on the glass surface, bars 5 µm. 
In a slight variation of the previous experiment the protein was applied near a 
vesicle that was deflated on the cover glass (Figure 20C). Once again the emergence of 
bright round spots which grew by fusing together preceded the membrane budding (see 




An attempt to label the protein on its five cysteine aminoacids using Cy3 
maleimide compound was made as described in Materials and Methods section. The 
resulting labeled product had 4 dye molecules per protein molecule. However, while the 
labeled protein was able to bind uniformly to the membrane of the GUV, no self assembly 
into round domains was observed (Figure 21). This lack of self-assembly correlated with 
lack of budding activity: in none of the 10 experiments performed with the labeled protein 
was internal vesicle formation observed. It is likely that the labeling of some of the 5 
cysteines present in the matrix protein impeded electrostatic interactions between M 
proteins. 
 
Figure 21. Adsorption of M proteins labeled by Cy3 fluorophores on GUV membrane. The labeled M 
protein (0.5 µM) was applied from a delivery pipette placed near a GUV, as seen in the first two frames 
showing bright-field images. Subsequent fluorescence images (time in seconds) show adsorption of labeled 
M proteins on the GUV. Note that no membrane deformations are visible. Upon M protein adsorption, 
GUV remained uniformly labeled (frame 2-6). Bar 3 µm. 
Though no direct observations of the functional proteins could be made, the 
results of the experiments on GUV containing self-quenched rhodamine in the membrane 
clearly demonstrated the formation of domains that bud away from the membrane. 
Altogether, the experimental data obtained on LUV and GUV show that these domains 




section it can be extrapolated that dequenching of rhodamine florescence, also observed 
in GUV, correlates with protein adsorption on the membrane. Unidirectional membrane 
budding that follows the protein adsorption, directly indicates that budding domains 
contain M proteins imposing negative curvature – if they were “holes” (circles) of pure 
bilayer, then bidirectional budding would be the likely outcome. It can be also excluded 
that M proteins form a rigid sheet from which membrane bud tears out; multiple budding 
event from a patch would not be possible. The lack of budding in the absence of bright 
domains is indicative of protein self-assembly on membrane surface as an important step 
in the vesiculation progress. Finally, efficient formation of vesicles from a patch of GUV 
membrane (Figure 19) demonstrates that the budding is a localized event rather than a 
consequence of bulk shape transformations of a GUV that can be caused by massive 
protein adsorption (Tsafrir et al., 2003). 
As can be observed in the Figure 22, vesicle formation was more effective when 
cholesterol or charged lipids were present in the GUV composition. As shown above, the 
binding efficiency of M protein to LUVs was not affected by the membrane charge 
(Figure 16A). Thus, charge lipids enhance the budding activity of already bound M 
proteins. Cholesterol, on the other hand, stimulates both adsorption and budding activity 
of M protein. Notably, with the addition of 30 molar % of cholesterol, which doubles the 
bending rigidity of the GUV membrane (Henriksen et al., 2004), the budding efficiency 
of M protein was not diminished but rather augmented (Figure 22). This finding 
demonstrates that cholesterol, an abundant component in the NDV membrane, can 
actively participate in virus budding (Laliberte et al., 2007). Interestingly, the presence of 
PE also increased protein adsorption and supported effective membrane budding (see 






Figure 22. Effect of M protein and BSA adsorption on the morphology of the GUVs with different lipid 
compositions. M protein (4 µM) or BSA (4 µM) was applied from a delivery pipette. Images were taken 
before (upper row) and ~2 minutes after (lower row) the protein application; representative images of 3 
independent experiments are shown; bar 2 µm. 
Overall, vesicle formation and changes in membrane fluorescence were detected 
with 4 different batches of M protein (18 experiments total). No comparable changes 
were observed on GUVs perfused with buffer containing no protein or 4 µM BSA (Figure 
22). The spatial resolution of fluorescence microscopy, limited to ∼micron size objects, 
did not allow for detection of smaller vesiculation events comparable with those expected 
for a NDV particle (100-300 nm). However, these experiments show that through 
interactions with lipid bilayer, M protein implements the genetically encoded information 
required to create the closed spherical membrane particles; thus virus geometry resides 
with its M protein. 
To characterize smaller budding events induced by M proteins on a lipid bilayer 










3.4. Budding activity of matrix protein monitored by admittance measurements 
 
As in experiments with GUV, a small patch of a BLM was isolated inside a patch-
pipette containing M protein solution. Changes in the electrical admittance of the patch 
were monitored as described in Materials and Methods.  
To proceed with further analysis of experimental data it is instructive to review the 
expected changes in the equivalent electrical circuit of the membrane patch during a 
budding event (Figure 23). Assuming that M protein mediates formation of spherical 
particles from the membrane patch, as it does on a plasma membrane or in GUV 
experiments described above, the growing bud would retrieve the “initial” area of the 
patch (Figure 23A, yellow). Consequently, the total membrane area localized within the 
patch pipette would increase as additional area is retrieved from reservoir (blue in Figure 
23B). The apparent electrical capacitance of the patch, proportional to the total membrane 
area inside the pipette, will increase as well. If the bud finally pinches off (as in cellular 
systems (Rosenboom and Lindau, 1994)), the membrane area inside the patch will 
decrease and the capacitance (∆Im) will return to its initial level (Figure 23C).  
 
Figure 23. Changes in the equivalent electrical circuit of a membrane patch during budding of small 
spherical vesicles. A. A large planar BLM attached to a lipid reservoir is patch-clamped by a narrow glass 
pipette isolating a small membrane patch (yellow) (Melikov et al., 2001). The intact patch has very small 
ionic permeability and thus is characterized only by its electrical capacitance, Cpatch. B. When a vesicle is 
derived from the patch it recruits its initial membrane (yellow) and additional membrane is retrieved from 
the reservoir (blue) to satisfy boundary conditions for the stable patch (it is assumed that vesicle formation 
does not affect the contact between the membrane and the pipette). The equivalent circuit now includes 3 
additional elements: Cbud corresponds to the bud area; Rneck corresponds to the access resistance of the neck 
connecting the vesicle and the membrane patch at the late stage of budding; Rl corresponds to the leakiness 
of the vesicle membrane; all elements can be calculated from measured changes of the equivalent 
admittance (∆Im and ∆Re) and DC-conductance (Gdc) of the membrane system within the pipette (Lollike 




Indeed, such periodic changes in ∆Im were observed experimentally. The increase 
was seen as a gradual growth in ∆Im from its initial level (init and fin in Figure 24A) 
followed by sharp a decrease in ∆Im, likely corresponding to completion of the bud 
formation and detachment of the newly formed vesicle. In the presence of a lipid 
reservoir, multiple changes were seen: buds formed one by one (as in Figure 24A) or the 
simultaneous growth of several buds was seen (as in Figure 24B). While one large buds 
(corresponding to level 1 in ∆Im tracing, Figure 24B) developed slowly, smaller bud can 
form and pinch off (e.g. note the changes of ∆Im around level 2, Figure 24B).  
 
Figure 24. Electrical admittance measurements reveal individual budding events. A. Changes in the 
imaginary part of the admittance (∆Im) during consecutive formation of several buds: ∆Im increases from 
the initial levels (init) until reach the final one (fin) during formation of a single budding vesicle; after the 
vesicle pinches off ∆Im returns to its initial level (see also panel D). B. Changes of the imaginary and real 
(∆Re) parts of the admittance and ionic permeability (Gdc) of the membrane patch upon application of M 
protein (2 µM); level 1 shows the background level of ∆Im, which corresponds to the initial area of the 
patch; ∆Im deviations from level 1 indicate reversible changes in the patch area, when each single 
alteration (e.g. around level 2) indicates a budding event. C. Similar measurements for the patch 
disconnected from the membrane reservoir; note the drift of the init level indicating the constant decrease 
of the patch area. D. The scheme outlines changes in membrane admittance during a budding event in 
which a metastable membrane neck forms; levels in and fin show the ∆Im increase due to formation of a 
bud; in ∆Re channel the red arrow indicates bud closure, while the blue arrow indicates fission of the neck; 




The connection of the membrane patch to the external lipid reservoir was critical 
to see consecutive budding. Figure 24C outlines changes of the admittance in experiments 
with no lipid reservoir. The budding still proceeded owing to the excess lipids left on the 
pipette or stored in undulations of the membrane patch, but formation of buds quickly 
depleted these reservoirs resulting in an irreversible alteration of the patch membrane 
seen as a continuous decrease in the level to which ∆Im returned (Figure 24C, init and 
init’).  
Fast drops in ∆Im did not always indicate the complete detachment of a vesicle. 
Rarely, after bud closure, the conductance of a thin neck connecting the bud and the 
membrane patch was resolved, analogous to the pinching-off of an endosome in a cellular 
system (Rosenboom and Lindau, 1994). When a bud starts forming, the neck conductance 
is very large. From equation (6) (Materials and Methods) it is seen that ∆Re is greater 
than zero only when the neck conductance Gn becomes comparable with the admittance 
of the bud membrane (Gn/ωCbud~1), which for a typical bud size of ~100 nm corresponds 
to ~100 pS. Such narrow necks (few nanometers in diameter) form only at the latest 
stages of budding, thus for most of the process ∆Re is close to zero and only changes in 
∆Im proportional to the bud capacitance (or bud area) are seen. However, Figure 24D 
shows a transient increase in ∆Re after the ∆Im drop, which corresponds to the formation 
of the neck (see equation (9) in Material and Methods). The neck conductance was 
detected for some time after the ∆Im drop. While ∆Im grew again due to formation of the 
next bud, the neck conductance dropped below the level of resolution (Figure24D, 
arrows). Thus, the membrane bud first closed abruptly (∆Im drops), which was likely due 
to instability of the membrane connection between the forming bud and the membrane 
patch under tension (Frolov et al., 2003). Then, the thin neck fissions or elongates so that 
its conductance is not resolved anymore. Usually the neck conductance drops soon after 
bud closure and much faster than the characteristic time of bud growth, as shown in 
Figure 24D. In such cases the amplitude of the ∆Re increase was much smaller than one 
of the preceding ∆Im drops, indicating that the neck quickly became narrow (see 
equivalent circuit in Figure 23 and equation (7) in Material and Methods). In such 
budding events the value of the ∆Im jump approached Cbud, proportional to the total bud 




histogram in Figure 25A. Occasionally, fission pores were more conductive and stayed 
open longer, as in Figure 24B. No correlation between the value of the ∆Im jump and the 
fission pore behavior was obtained, indicating that the creation of membrane curvature by 
M protein is decoupled from membrane fission.  
 
Figure 25. Statistical analysis of the admittance measurements. A. A histogram showing the amplitude 
distribution for ∆Im jumps detected in experiments. B. Cumulative distribution of the amplitude of ∆Im 
jumps and corresponding diameter of spherical membrane particles; initial part of the distribution (up to 
~1.3 fF) is expanded to show its Gaussian-like profile. C. Left histogram shows the distribution of small 
∆Im jumps from C; right histogram shows distribution of ∆Im jumps obtained at elevated (5 µM) 
concentration of M protein. 
Importantly, detected admittance changes were not accompanied by any 
significant changes in the permeability of any membrane part within the patch pipette, as 
seen by the measurements of the direct current conductance (Gdc) of the membrane patch 
(Figure 24B). This finding is in agreement with the data on the hydrophobic profile of the 
M protein with no parts supporting extensive membrane insertion (Chambers et al., 
1986). The lack of leakage also supports the notion that the release of the LUV contents 
was not due to formation of a protein or proteolipid pores (Basanez et al., 2001).    
  The shape of the formed bud is closer to spherical rather than to cylindrical as the 
access resistance (Rpore) remained small until the buds close up. This is further confirmed 
by the budding observed on GUV system. Thus, the capacitance changes measured may 
be transformed into final bud diameters values by following equation (5) (Materials and 
Methods). 












=   (12) 
Figure 25A shows capacitance values obtained, from which the bud diameters in this 
spherical approximation can be estimated. The values are comparable with the size of 
NDV particles (ranging from ~0.1 to 0.5 µm), though the distribution is broad.  
The cumulative distribution function (CDF) of the values of ∆Im jumps is rather 
broad and skewed, with a pronounced singularity at ~1.3 fF (Figure 25B, 188 jumps in 
total). This singularity breaks the distribution into two parts. Smaller jumps (on the left 
form the break in Figure 25B) have normal size distribution, with mean value of 0.92+/-
0.17 fF (SD, n=40, Figure 25C, left histogram), corresponding to a spherical bud with a 
diameter of ~180 nm, close to the typical sizes of NDV particle (150- 300 nm) (Takimoto 
and Portner, 2004). Distribution of the larger jumps is close to log-normal, ranging from 
200 to 500 nm, consistent with the size heterogeneity of virus-like particles produced by 
M protein in cells (Pantua et al., 2006) and the vesicles observed in experiments with 
GUVs. Increasing the M protein concentration in the pipette to 5 µM led to an overall 
increase in the values of ∆Im jumps (2.7+/-1.1 fF SD, n=47; Figure25C, right histogram).  
 
Formation of vesicles from a planar bilayer with high lateral tension, σ (typically 
σ~10-3 N/m2) (Frolov et al., 2003), requires substantial energy to pull lipid material from 
the reservoir and bend it into a sphere. For a 100 nm vesicle, such energy would reach 
several thousand kBT, as: 
∆E ~ 8πk+σAbud,  (13) 
where Abud is the vesicle area and k is the bending modulus (as pointed in the introduction 
section, k ≈ 20 kBT for a typical phospholipid bilayer). However, if M proteins are as 
tightly packed on the vesicle membrane as inside the virus, the number of proteins per 
100 nm vesicle is over a thousand (e.g. at 0.05 protein/lipid ratio on the membrane 
surface, see Figure 16B and C). At such densities the energy cost to pull material and 
bend it into a sphere per protein is low (approaching several kBT). Thus, weak interactions 
between proteins and lipids in a membrane domain can sum up to provide enough energy 
for curvature creation. This estimation corroborates the notion that weak association of M 




Besides providing required energy, the same association of M proteins controls 
membrane geometry producing membrane vesicles of the desired shape. Long-range 
coordination of membrane deformations required for vesicle formation by M protein 
cannot be based on the intrinsic topology of a protein lattice, as in the case of a clathrin 
cage, but the proteolipid interactions, possible within a budding proteo-lipid domain, may 
contribute to particle formation, as discussed in the introduction of this manuscript. Thus, 
despite its intrinsic simplicity, weak protein condensation on a membrane surface 
provides a powerful tool to regulate membrane shape and topology. To further investigate 
the nature of such budding domains, a different experimental approach was used, where 
the behavior of the protein on a lipid monolayer was studied. 
 
 
3.5. Fluid-like behavior of domains assembled by matrix protein on lipid monolayers 
 
As discussed in the previous section, M protein driven budding relies on the 
formation of proteo-lipid domains. In the introductory part of this manuscript two types of 
membrane domains were described: the gel-liquid phase domains (or crystalline domains) 
and the liquid-ordered:liquid-disordered domains (or fluid-like domains). As summarized 
in Table 3, the fluidity of flat membrane domains is expressed in their quasi-circular form 
and tendency to merge minimizing the boundary energy. Further minimization of the 
boundary energy is possible when domains take advantage of the third dimension and bud 
away. In contrast, crystalline domains have irregular shape and generally grow along 
certain polymerization patterns, rather than by domain merger. The data described 
previously provides arguments in favor of the fluidity of the M protein induced 
membrane domains. The bright round spots that have been identified as protein 
containing domains grew by merger, as can be seen from Figure 20. Admittance 
measurements revealed a broad distribution in the sizes of the budding vesicles. A 
described earlier, the merger of budding domains is likely to account for the broadness of 
the size distribution. However, neither the microscopic observation nor the admittance 
measurements directly demonstrates the microstructure of the domains. To assay finite 
details of the M protein membrane assemblies, electron microscopy imaging of the 




in detail previously, the monolayer system has intrinsic constrains to the budding activity 
of the protein due to the extremely high surface tension of the air-water interface. This 
way, the protein added to the lipid monolayer from the side of the lipid head-group will 
be trapped flat in two-dimensions. The results of such experiments are shown on Figure 
26, where tight assembly of M proteins into circular domains on the lipid surface was 
confirmed on a nanometer scale by transmission electron microscopy observations. 
Circular patterns corresponding to aggregating proteins were detected after M protein 
adsorption on the lipid monolayer and no such objects were detected in control 
experiments when only M protein or only lipid monolayers were applied. 
 
Figure 26. Electron microscopy study of M protein condensation on a lipid monolayer. White arrows 
show the round proteo-lipid domains. Bars 50 nm. 
            Another way to explore the fluidity of proteo-lipid domains is to measure changes 
in the lipid monolayer surface pressure induced by the protein. This was done using the 
Wilhelmy balance as described in materials and methods. The typical plot of surface 
pressure versus area per molecule of a DOPC monolayer containing 10% of cholesterol is 
seen as a solid line in Figure 27A. Here the transition from the gas phase into a liquid 
phase is indicated by the change in the slope of the curve before the monolayer collapse. 
When M protein was added into the subphase in the presence of such monolayer, the 





Figure 27. Interaction of M protein with lipid monolayer on air-water interface. A. Surface pressure-area 
isotherms (at room temperature) of pure DOPC:Cholesterol (9:1, 0.27 mM) monolayer (solid line) and of 
DOPC:Cholesterol (9:1, 0.27 mM) monolayer compressed in the presence of 0.54 nM of M protein (dashed 
line); in the latter experiments the lipid monolayer was pre-formed in the absence of the protein and then 
compressed after addition of the protein. B. β-π plot for pure M protein (0.54 nM; red solid line), 
DOPC:Cholesterol monolayer (0.27 mM; blue dash line) and M protein (0.54 nM) applied to a pre-formed 
DOPC:Cholesterol monolayer (0.27 mM; magenta, dash-doted line). 
These data can be re-plotted as the compressibility coefficient versus surface 

















δβ 1 ,   (14) 
where A is the area per molecule and π is the surface pressure. It is interesting to note that 
M protein adsorbed only weakly onto the air-water interface in the absence of the lipid 
monolayer (Figure 27B, solid line).  For the pure lipid monolayer, the compressibility 
coefficient grew slightly until reach a maximum around 26 mN/m before the collapse of 
the film (Figure 27B, dash line). Addition of the protein to a pre-compressed lipid 
monolayer (Material and Methods) changed the behavior of the β (Figure 27B, dash-dot 
line). First, a plateau was seen until the surface pressure reached ~12 mN/m. At this point, 
which corresponds to the kink in Figure 27A, a very pronounced growth in the curve 
slope occurred until reaching a maximum at 26 mN/m. The asymmetry of the curve 
indicates that phase transitions could proceed in several steps. 
These data strongly indicate that the lipid monolayers with bound M proteins have 




solidification of the monolayer happened (e.g. formation of a crystalline or gel phase 
induced by the protein adsorption), the surface pressure values near the new kink should 
be much higher (usually at 30-40 mN/m) (Cruz and Perez-Gil, 2007). Rather, low surface 
pressure value at the new kink (~12 mN/m) indicates ordering of the liquid phase 
(consistently with formation of fluid-like proteo-lipid domains). The maximum value of 
the compressibility coefficient is larger in the presence of the protein, which indicates 
higher intermolecular cooperativity in the proteo-lipid film (Kamilya et al., 2007). 
Altogether, the experiments on M protein interaction with lipid monolayers provide 




3.6. Modeling a proteo-lipid fluid domain budding: simple energy considerations 
 
The experimental data presented above were further analyzed theoretically in the 
framework of Lipowsky’s model for the budding of a membrane fluid domain (Lipowsky, 
1992) (see Introduction section). In this model, the energy of a fluid domain budding 
from a lipid membrane is equal to the sum of the bending energy of the bilayer plus the 
edge energy of the domain (originating from the line tension on the domain periphery).  
)( edgebendLip EEE +=   (15) 
If the domain forms a spherical cap with curvature C (radius of curvature R=1/C) and 
opening radius N (Figure 28), then the bending energy of the domain is given by: 
22 )(2)22(
2 spspbend
LCLCkCCAkE −=−= π  (16) 
where A is the surface area (A=πL2, see Figure 14) and k is the bending rigidity of the 







Figure 28. Geometrical parameters of a membrane domain (b) forming a spherical bud. The area of the 
bud is defined as Aβ = π L2, the bud curvature as C=1/R and the neck radius is N. Adapted from Lipowsky, 
1992. 
The edge energy of the domain is given by: 
2)2/(122 LCLNEedge −== πσπσ   (17) 
where σ denotes line tension of the domain boundary. For lipid domains the value of the 
line tension can be estimated as 10-11N (Lipowsky, 1992). However, the line tension can 
be different for domains assembled with the help of proteins (such as M protein 
molecules). The edge length is defined as 2πN, where N = 2)2/(1 LCL − (Lipowsky, 
1992).  
As postulated by Lipowsky: “a flat domain with surface area A embedded in a flat 
membrane matrix will form a circular disk of radius L = (A/π) 2 in order to attain a state 
with a minimal value, 2πL, for the length of its edge. The edge can be further reduced if 
the domain deforms into the “third dimension” and form a bud”. However, as noted by 
Lipowsky, to perform budding the domain should reach a certain size (Lc), so that the 
edge energy exceeded the curvature energy of the bud. Figure 29A illustrates the 
dependence of this energy defined by Lipowsky (ELip) on the domain curvature (LC) for 
domains of different size. All curves have two similar minima (at ±2 LC) which 
correspond to closed vesicles budded in opposite directions from the membrane plane. 
The minimum at LC=0, indicating a stable flat (C=0) domain, is seen for small domains 
(Figure 29A, red curve), but absent from larger domains (Figure 29A, blue curve). The 
black curve (Figure 29A) corresponds to the critical size of the domain (Lc) at which the 





Figure 29. Fluid domain budding: energy components consideration. A. Dependence of the domain 
energy defined by Lipowsky in absence of line tension (ELip) on curvature (LC) for domains of different 
sizes. Budding occurs in the extreme minima. The minimum at LC=0, that appear for smaller domain (red 
curve) indicates stable flat domains. This minimum does not exist in larger domains (blue curve). The black 
curve corresponds to the critical size of the domain, at which the minimum at LC=0 disappears. Domain 
spontaneous curvature is considered zero. B. Behavior of the energy that includes the line tension term as a 
function of LC for different L. The minimum at LC=0 appears at higher L values, indicating that large flat 
domains are as stable as the small ones. Domain spontaneous curvature is considered zero. C. Second 
derivation of the energy from B over L (E"(L)) at LC=0. The E"(L) dependence is showed for two values of 
the lateral tension. For large tension E"(L) is always positive, so that flat domains are stable. For small 
tension, a region of instability appears (from Lc1 to Lc2) where growing domains bud spontaneously, as the 
energy had a maximum for that L values. D. Behavior of the energy as a function of LC when a non-zero 
spontaneous curvature of the growing domain is considered. The inclusion of a small negative spontaneous 
curvature into the energy equation (2% difference in cholesterol concentration between the membrane 
monolayers is considered for the plot represented) produces a broadening of the size distribution of the 
resulting buds toward. The energy curvature presents pronounced asymmetry, thus securing the 
unidirectional budding toward the negative curvature. 
Though this theory was created for purely lipidic fluid domains, the same principles can 
be applied to describe budding of fluid domains formed by M protein. In this case the line 
tension occurs on the boundary of the proteolipid domains (seen in Figure 20 or 26) 
created by M proteins. For simplification, it is further assumed that M proteins influence 




curvature Csp, However, two more energy terms should be taken into account. First, when 
a vesicle is formed from a lipid bilayer connected to a reservoir (e.g. BLM, Figure 24), 
the surface tension (σ) of the membrane has to be included. Second, the energy of M 
protein association into a domain should be taken into account. If the difference in 
chemical potentials for a protein inside and outside of the domain (µ-µo) is assumed fixed, 
the association energy will be simply proportional to the domain area. These two terms 
constitute the surface energy of the domain: 









LNLEsurf ,  (18) 
where γ is the surface tension of the membrane and a is the area occupied by M protein 
on the membrane. The measured value of γ for membranes used in this work varies 
between ~10-13 N/nm (BLM) and 0.1*10-13 N/nm (GUV). In the framework of this simple 
analysis, a value of 4*10-13 N/nm is used. The total energy of the domain can be rewritten 
as: 
)( surfedgebend EEEE ++=  (19) 
Combining formulae 16-19, the total energy of the domain, normalized for k, is: 
)")/()'/()2/(1)/()((2 22222 ξξξπ LCLLLCLLCLCE sp −+−+−= , (20) 
where ξ =k/σ, γξ /8' k= and ξ ”= )( 0µµ − /2aσ. For convenience, this energy will be 
presented in kBT units where T is the temperature in Kelvins and kB is the Boltzmann 
constant.  
In Figure 29B the behavior of E as a function of LC is presented for different L. 
As in the case of lipid domains presented above (Figure 29A), the spontaneous curvature 
of the domain is neglected. Figure 29B shows that budding is possible only for certain 
range of L values: the minimum at LC=0, seen for small domains in Lipowsky model, 
appears at large L values, indicating that large flat domains become stabilized by lateral 
tension of the membrane. This range of L is determined by the ratio between line and 
lateral tensions and bending rigidity of the domain. If the minimum at LC=0 exists, then 
the second derivation of E” over L at LC=0 ( ) should be negative. The 
dependence of  on L is showed on Figure 29C for different values of the 
lateral tension. For large tensions E” is always positive so that flat domains are stable. 
For smaller tensions a region of instability appears (Figure 29C, from L
)0( =LCEllLL
)0( =LCEllLL




growing domains bud spontaneously. This region is centered at ~150 nm (comparable 
with experimentally observed values for M protein domains), for an intermediate tension 
(0.3-0.5 dyn/cm), bending rigidity of 50-70kT and a line tension of 70 pN.  
In the experiments with M protein, the vesicles formed in a unidirectional way 
toward the negative curvature of the bud (Figures 19, 20 and 22). M proteins interact 
directly only with one monolayer of the membrane, thus the budding proceeds 
asymmetrically and the spontaneous curvature of the growing domain should be also 
taken into account. Introducing the non-zero spontaneous curvature changed slightly the 
effect of the lateral tension described above. As can be observed in Figure 29D, the 
region of spontaneous budding of the growing domain is now slightly expanded toward 
larger domain sizes (e.g. the intermediate minimum does not appear until bigger L value, 
Figure 29D, green line), thus making the size distribution of the resulting buds broader. 
Importantly, the energy curve is now skewed to one side so that creation of buds with 
negative curvature is promoted (Figure 29D). Notably, only minor changes in 
spontaneous curvature induce pronounced asymmetry in the energy curve, thus securing 
the unidirectional budding. Such changes can be due, for example, to small asymmetry in 
cholesterol distribution introduced by M proteins.  
Finally, to illustrate the whole budding process the energy dependence on L and 
LC is presented in Figure 30. Domains grow to cross the energy barrier and then either 
bud (Figure 30, red arrow to the left) or continue growing flat (Figure 30, white arrow). 
This implies other mechanisms for the formation of bigger vesicles. As the budding 
domains are considered fluid, these bigger vesicles may form by merging of smaller 
domains in order to avoid the high energy cost of direct domain budding. But this 
mechanism is outside of the framework of the present model. 
In conclusion, the model presented here supports the idea of membrane budding 
by fluid proteolipid domains. The size of the budding vesicles is controlled not via a 
scaffold of predetermined geometry, but via a careful balance between different forces 
defining the energetics of the budding process. The energy per protein needed for a 
proteolipid domain to undergo budding is of the order of a few kBT, in accordance with 
the result obtained by the theoretical work on fluid domain budding (Lipowsky, 1992). 
The intrinsic curvature of the proteolipid fluid domain provides unidirectionality to the 





Figure 30. Three dimentional representation of the energy dependence of the budding process on the 
size and curvature of the growing domain. Domains should grow to reach certain size and cross the energy 
barrier. After that point, the domain may choose between budding (indicated as red arrow to the left) or 
continue growing flat (white arrow). 
 
smallest proteolipid vesicles. The spontaneous curvature may come from cholesterol 
segregation with the M protein. Also, experimental data suggest that in the absence of 
cholesterol, M protein may induce budding if DOPE is present in the system (Figure 22). 
DOPE has larger negative spontaneous curvature than cholesterol, so smaller 
redistributions of this lipid will lead to the same result of unidirectionality of budding. 
However, the ability of M protein to induce unidirectional budding of charged 
membranes without the presence of any lipid with negative curvature, suggest that 
membrane assembly of M proteins imposes negative curvature independently on the 
lipids. This ability is to be explored more deeply in future studies. 
 
 
In order to shake a hypothesis, it is sometimes not 
necessary to do anything more than push it as far as 




















1. Matrix protein of Newcastle Disease Virus is sufficient to produce membrane 
budding upon its adsorption on a lipid membrane. The size distribution of the vesicles 
budded from the lipid membrane is in good agreement with the size distribution of 
viral particles produced in vivo. Thus, M protein possesses the energy and the intrinsic 
geometrical information to induce budding in cells without the help of other cellular 
machineries. 
 
2. M protein of NDV organizes domains on the lipid membrane. Lipids in such 
domains have limited mobility and the components of the system organize into a new 
fluid-like phase, as evidenced by their rounded shape and ability to fuse together.  
 
3. Fluid-like domains originated by NDV matrix protein interaction with the 
membrane evolve by budding, confirming that the mechanism of domain driven 
budding is applicable for budding of enveloped viruses.  
 
4. NDV matrix protein binding and budding are dependent on the membrane lipid 
composition. While binding is enhanced by the presence of lipids with negative 
curvature, such as cholesterol or DOPE, it is not affected by the presence of charge in 
the membrane; the budding activity is enhanced in both cases.  
 
5. Budding of lipid membrane induced by its interaction with NDV matrix protein is 
unidirectional. Thus, matrix protein induces negative curvature upon its self-assembly 
on the membrane template. A model of unidirectional budding induced by NDV 
matrix protein indicates lipid distribution asymmetry, such as cholesterol 
concentration in one of the lipid leaflets, as an additional factor that contributes to the 
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n o n - g l y c o s y l a t e d  ma t r i x  p r o t e i n . "  
B i o c h i m  B i o p h y s  A c t a  9 9 9 ( 2 ) : 1 7 1 - 5  
 
G a r o f f ,  H . ,  R .  H e w s o n  a nd  D . J .  O p s t e l t e n  ( 1 9 9 8 ) .  
" V i r u s  m a t u r a t i o n  b y  b u d d i n g . "  
M i c r o b i o l  M o l  B i o l  R e v  6 2 ( 4 ) : 1 1 7 1 - 9 0  
 
G i u f f r e ,  R . M . ,  D . R .  T o v e l l ,  C . M .  K a y  a n d  D . L .  T y r r e l l  ( 1 9 8 2 ) .  
" E v i d e n c e  f o r  a n  i n t e r a c t i o n  b e t w e e n  t h e  m e m b r a n e  p r o t e i n  o f  a  
p a r a my x o v i r u s  a n d  a c t i n . "  
J  V i r o l  4 2 ( 3 ) : 9 6 3 - 8  
 
G o r t e l ,  E .  a n d  F .  G r e n d e l  ( 1 9 3 5 ) .  
" O n  b i o m o l e c u l a r  l a y e r s  o f  l i p o i d s  o n  c h r o ma t o c y t e s  o f  b l o o d . "  
J .  E x p .  M e d i c i n e  4 1 : 4 3 9 - 4 4 3  
 
G r u n e r ,  S . M . ,  P . R .  C u l l i s ,  M . J .  H o p e  a n d  C . P .  T i l c o c k  ( 1 9 8 5 ) .  
" L i p i d  p o l y mo r p h i s m:  t h e  mo l e c u l a r  b a s i s  o f  n o n b i l a y e r  p h a s e s . "  
A n n u  R e v  B i o p h y s  B i o p h y s  C h e m  1 4 : 2 1 1 - 3 8  
 
H a n ,  G . Z . ,  C . Q .  H e ,  N . Z .  D i n g  a n d  L . Y .  M a  ( 2 0 0 8 ) .  
" I d e n t i f i c a t i o n  o f  a  n a t u r a l  m u l t i - r e c o m b i n a n t  o f  N e w c a s t l e  d i s e a s e  
v i r u s . "  
V i r o l o g y  3 7 1 ( 1 ) : 5 4 - 6 0  
 
H a n ,  Z .  a n d  R .  H a r t y  ( 2 0 0 5 ) .  




V i r o l o g y  J o u r n a l  2 ( 1 ) : 9 2  
 
H a n s o n ,  P . I . ,  R .  R o t h ,  Y .  L i n  a n d  J . E .  H e u s e r  ( 2 0 0 8 ) .  
" P l a s m a  m e m b r a n e  d e f o r m a t i o n  b y  c i r c u l a r  a r r a y s  o f  E S C R T - I I I  
p r o t e i n  f i l a me n t s . "  
J  C e l l  B i o l  1 8 0 ( 2 ) : 3 8 9 - 4 0 2  
 
H a r d e n ,  J . L . ,  F . C .  M a c k i n t o s h  a n d  P . D .  O l ms t e d  ( 2 0 0 5 ) .  
" B u d d i n g  a n d  d o ma i n  s h a p e  t r a n s fo r m a t i o n s  i n  m i x e d  l i p i d  f i l ms  
a n d  b i l a y e r  m e m b r a n e s . "  
P h y s  R e v  E  S t a t  N o n l i n  S o f t  M a t t e r  P h y s  7 2 ( 1 ) : 0 1 1 9 0 3  
 
H e l f r i c h ,  W.  ( 1 9 7 3 ) .  
" E l a s t i c  p r o p e r t i e s  o f  l i p i d  b i l a y e r s :  t he o r y  a n d  p o s s i b l e  
e x p e r i me n t s . "  
Z  N a t u r f o r s c h  [ C]  2 8 ( 1 1 ) : 6 9 3 - 7 0 3  
 
H e n r i k s e n ,  J . ,  A . C .  R o w a t  a n d  J . H .  I p s e n  ( 2 0 0 4 ) .  
" V e s i c l e  f l u c t u a t i o n  a na l y s i s  o f  t h e  e f f e c t s  o f  s t e r o l s  o n  m e m b r a n e  
b e n d i n g  r i g i d i t y . "  
E u r  B i o p h y s  J  3 3 ( 8 ) : 7 3 2 - 4 1  
 
H i g g i n s ,  M . K .  a n d  H . T .  M c M a h o n  ( 2 0 0 5 ) .  
" I n  v i t r o  r e c o n s t i t u t i o n  o f  d i s c r e t e  s t a g e s  o f  d y n a mi n - d e p e n d e n t  
e n d o c y t o s i s . "  
M e t h o d s  E n z y m o l  4 0 4 : 5 9 7 - 6 1 1  
 
H o r v a t h ,  J . C . ,  A .  H o r a k ,  J . G .  S i n k o v i c s ,  M .  P r i t c h a r d ,  S .  P e n d l e t o n  
a n d  E .  H o r v a t h  ( 1 9 9 9 ) .  
" C a n c e r  v a c c i n e s  w i t h  e m p h a s i s  o n  a  v i r a l  o n c o l y s a t e  me l a n o ma  
v a c c i n e . "  
A c t a  M i c r o b i o l  I m m u n o l  H u n g  4 6 ( 1 ) : 1 - 2 0  
 
H u r l e y ,  J . H .  ( 2 0 0 8 ) .  
" E S C R T  c o mp l e x e s  a n d  t h e  b i o g e n e s i s  o f  mu l t i v e s i c u l a r  b o d i e s . "  
C u r r e n t  O p i n i o n  i n  C e l l  B i o l o g y  
C e l l  s t r u c t u r e  a n d  d y n a m i c s  2 0 ( 1 ) : 4 - 1 1  
 
H u r l e y ,  J . H .  a n d  S . D .  E mr  ( 2 0 0 6 ) .  
" T h e  E S C R T  c o m p l e x e s :  s t r u c t u r e  a n d  m e c h a n i s m  o f  a  m e m b r a n e -
t r a f f i c k i n g  n e t w o r k . "  
A n n u  R e v  B i o p h y s  B i o m o l  S t r u c t  3 5 : 2 7 7 - 9 8  
 
I s r a e l a c h v i l i ,  J . N .  ( 1 9 7 7 ) .  
" R e f i n e m e n t  o f  t h e  f l u i d - mo s a i c  mo d e l  o f  me mb r a n e  s t r u c t u r e . "  
B i o c h i m  B i o p h y s  A c t a  4 6 9 ( 2 ) : 2 2 1 - 5  
 




" I n t r a c e l l u l a r  t r a n s p o r t  o f  s e c r e t o r y  p r o t e i n s  i n  t h e  p a n c r e a t i c  
e x o c r i n e  c e l l .  I .  R o l e  o f  t h e  p e r i p h e r a l  e l e m e n t s  o f  t h e  G o l g i  
c o mp l e x . "  
J  C e l l  B i o l  3 4 ( 2 ) : 5 7 7 - 9 6  
 
J a m i e s o n ,  J . D .  a n d  G . E .  P a l a d e  ( 1 9 6 7 b ) .  
" I n t r a c e l l u l a r  t r a n s p o r t  o f  s e c r e t o r y  p r o t e i n s  i n  t h e  p a n c r e a t i c  
e x o c r i n e  c e l l .  I I .  T r a n s p o r t  t o  c o n d e n s i n g  v a c u o l e s  a n d  z y m o g e n  
g r a n u l e s . "  
J  C e l l  B i o l  3 4 ( 2 ) : 5 9 7 - 6 1 5  
 
J a n k e ,  M . ,  B .  P e e t e r s ,  O .  d e  L e e u w ,  R .  M o o r ma n ,  A .  A r n o l d ,  P .  
F o u r n i e r  a n d  V .  S c h i r r m a c h e r  ( 2 0 0 7 ) .  
" R e c o mb i n a n t  N e w c a s t l e  d i s e a s e  v i r u s  ( N D V )  w i t h  i n s e r t e d  g e n e  
c o d i n g  f o r  G M - C S F  a s  a  n e w  v e c t o r  f o r  c a n c e r  i m m u n o g e n e  
t h e r a p y . "  
G e n e  T h e r  1 4 ( 2 3 ) : 1 6 3 9 - 4 9  
 
J a y a k a r ,  H . R . ,  E .  J e e t e n d r a  a n d  M . A .  Wh i t t  ( 2 0 0 4 ) .  
" R h a b d o v i r u s  a s s e mb l y  a n d  b u d d i n g . "  
V i r u s  R e s  1 0 6 ( 2 ) : 1 1 7 - 3 2  
 
J i n ,  A . J . ,  K .  P r a s a d ,  P . D .  S mi t h ,  E . M .  L a f e r  a n d  R .  N o s s a l  ( 2 0 0 6 ) .  
" M e a s u r i n g  t h e  e l a s t i c i t y  o f  c l a th r i n - c o a t e d  v e s i c l e s  v i a  a t o m i c  
f o r c e  mi c r o s c o p y . "  
B i o p h y s  J  9 0 ( 9 ) : 3 3 3 3 - 4 4  
 
J o u v e n e t ,  N . ,  S . J .  N e i l ,  C .  B e s s ,  M . C .  J o h n s o n ,  C . A .  V i r g e n ,  S . M .  
S i m o n  a n d  P . D .  B i e n i a s z  ( 2 0 0 6 ) .  
" P l a s ma  me mb r a n e  i s  t h e  s i t e  o f  p r o d u c t i v e  H I V - 1  p a r t i c l e  
a s s e mb l y . "  
P L o S  B i o l  4 ( 1 2 ) :  e 4 3 5  
 
K a mi l y a ,  T . ,  P .  P a l  a n d  G . B .  T a l a p a t r a  ( 2 0 0 7 ) .  
" I n t e r a c t i o n  o f  o v a l b u mi n  w i t h  p h o s p h o l i p i d s  L a n g mu i r - B l o d g e t t  
f i l m . "  
J  P h y s  C h e m  B  1 1 1 ( 5 ) : 1 1 9 9 - 2 0 5  
 
K i r k h a m ,  M .  a n d  R . G .  P a r t o n  ( 2 0 0 5 ) .  
" C l a t h r i n - i n d e p e n d e n t  e n d o c y t o s i s :  n e w  i n s i g h t s  i n t o  c a v e o l a e  a n d  
n o n - c a v e o l a r  l i p i d  r a f t  c a r r i e r s . "  
B i o c h i m  B i o p h y s  A c t a  1 7 4 6 ( 3 ) : 3 4 9 - 6 3  
 
L a l i b e r t e ,  J . P . ,  L . W.  M c G i n n e s  a n d  T . G .  M o r r i s o n  ( 2 0 0 7 ) .  
" I n c o r p o r a t i o n  o f  F u n c t i o n a l  H N - F  G l y c o p r o t e i n - C o n t a i n i n g  
C o mp l e x e s  i n t o  N e w c a s t l e  D i s e a s e  V i r u s  I s  D e p e n d e n t  o n  
C h o l e s t e r o l  a n d  M e m b r a n e  L i p i d  R a f t  I n t e g r i t y "  





L a n g h o r s t ,  M . F . ,  A .  R e u t e r  a n d  C . A .  S t u e r me r  ( 2 0 0 5 ) .  
" S c a f f o l d i n g  mi c r o d o ma i n s  a n d  b e y o n d :  t h e  f u n c t i o n  o f  
r e g g i e / f l o t i l l i n  p r o t e i n s . "  
C e l l  M o l  L i f e  S c i  6 2 ( 1 9 - 2 0 ) : 2 2 2 8 - 4 0  
 
L i ,  J . K . ,  T .  M i y a k a w a  a n d  C . F .  F o x  ( 1 9 8 0 ) .  
" P r o t e i n  o r g a n i z a t i o n  i n  N e w c a s t l e  d i s e a s e  v i r u s  a s  r e v e a l e d  b y  
p e r t u r b a n t  t r e a t me n t . "  
J  V i r o l  3 4 ( 1 ) : 2 6 8 - 7 1  
 
L i ,  L .  a n d  J . X .  C h e n g  ( 2 0 0 6 ) .  
" C o e x i s t i n g  s t r i p e -  a n d  p a t c h - s h a p e d  d o m a i n s  i n  g i a n t  u n i l a me l l a r  
v e s i c l e s . "  
B i o c h e m i s t r y  4 5 ( 3 9 ) : 1 1 8 1 9 - 2 6  
 
L i p o w s k y ,  R .  ( 1 9 9 2 ) .  
" B u d d i n g  o f  me mb r an e s  i n d u c e d  b y  i n t r a me mb r a n e  d o ma i n s . "  
J .  P h y s .  I I  F r a n c e  2 : 1 8 2 5 - 4 0  
 
L o l l i k e ,  K .  a n d  M .  L i n d a u  ( 1 9 9 9 ) .  
" M e mb r a n e  c a p a c i t a n c e  t e c h n i q u e s  t o  m o n i t o r  g r a n u l e  e x o c y t o s i s  
i n  n e u t r o p h i l s . "  
J  I m m u n o l  M e t h o d s  2 3 2 ( 1 - 2 ) : 1 1 1 - 2 0  
 
L o mn i c z i ,  B . ,  E .  We h ma n n ,  J .  H e r c z e g ,  A .  B a l l a g i - P o r d a n y ,  E . F .  
K a l e t a ,  O .  We r n e r ,  G .  M e u l e m a n s ,  P . H .  J o r g e n s e n ,  A . P .  M a n t e ,  
A . L .  G i e l k e n s ,  I .  C a p u a  a n d  J .  D a mo s e r  ( 1 9 9 8 ) .  
" N e w c a s t l e  d i s e a s e  o u t b r e a k s  i n  r e c e n t  y e a r s  i n  w e s t e r n  E u r o p e  
w e r e  c a u s e d  b y  a n  o l d  ( V I )  a n d  a  n o v e l  g e n o t y p e  ( V I I ) . "  
A r c h  V i r o l  1 4 3 ( 1 ) : 4 9 - 6 4  
 
M a l l a b i a b a r r e n a ,  A .  a nd  V .  M a l h o t r a  ( 1 9 9 5 ) .  
" V e s i c l e  b i o g e n e s i s :  t h e  c o a t  c o n n e c t i o n . "  
C e l l  8 3 ( 5 ) : 6 6 7 - 9  
 
M a r k w e l l ,  M . A . ,  S . M .  H a a s ,  L . L .  B i e b e r  a n d  N . E .  T o l b e r t  ( 1 9 7 8 ) .  
" A  m o d i f i c a t i o n  o f  t h e  L o w r y  p r o c e d u r e  t o  s i m p l i f y  p r o t e i n  
d e t e r mi n a t i o n  i n  me mb r a n e  a n d  l i p o p r o t e i n  s a m p l e s . "  
A n a l  B i o c h e m  8 7 ( 1 ) : 2 0 6 - 1 0  
 
M a r s h ,  M .  a n d  H . T .  M c M a h o n  ( 1 9 9 9 ) .  
" T h e  s t r u c t u r a l  e r a  o f  e n d o c y t o s i s . "  
S c i e n c e  2 8 5 ( 5 4 2 5 ) : 2 1 5 - 2 0  
 
M a r t i n ,  S .  a n d  R . G .  P a r t o n  ( 2 0 0 5 ) .  
" C a v e o l i n ,  c h o l e s t e r o l ,  a n d  l i p i d  b o d i e s . "  





M a r u s h c h a k ,  D . ,  S .  K a l i n i n ,  I .  M i k h a l y o v ,  N .  G r e t s k a y a  a n d  A . J .  
L B  ( 2 0 0 6 ) .  
" P y r r o me t h e n e  d y e s  ( B O D I P Y )  c a n  f o r m  g r o u n d  s t a t e  h o mo  a n d  
h e t e r o  d i me r s :  p h o t o p h y s i c s  a n d  s p e c t r a l  p r o p e r t i e s . "  
S p e c t r o c h i m  A c t a  A  M o l  B i o m o l  S p e c t r o s c  6 5 ( 1 ) : 1 1 3 - 2 2  
 
M a t s u o ,  H . ,  J .  C h e v a l l i e r ,  N .  M a y r a n ,  I .  L e  B l a n c ,  C .  F e r g u s o n ,  J .  
F a u r e ,  N . S .  B l a n c ,  S .  M a t i l e ,  J .  D u b o c h e t ,  R .  S a d o u l ,  R . G .  P a r t o n ,  
F .  V i l b o i s  a n d  J .  G r u e n b e r g  ( 2 0 0 4 ) .  
" R o l e  o f  L B P A  a n d  A l i x  i n  m u l t i v e s i c u l a r  l i p o s o m e  f o r m a t i o n  a n d  
e n d o s o m e  o r g a n i z a t i o n . "  
S c i e n c e  3 0 3 ( 5 6 5 7 ) : 5 3 1 - 4  
 
M a y e r ,  L . D . ,  M . J .  H o p e  a n d  P . R .  C u l l i s  ( 1 9 8 6 ) .  
" V e s i c l e s  o f  v a r i a b l e  s i z e s  p r o d u c e d  b y  a  r a p i d  e x t r u s i o n  
p r o c e d u r e . "  
B i o c h i m  B i o p h y s  A c t a  8 5 8 ( 1 ) : 1 6 1 - 8  
 
M c C r e e d y ,  B . J . ,  J r . ,  K . P .  M c K i n n o n  a n d  D . S .  L y l e s  ( 1 9 9 0 ) .  
" S o l u b i l i t y  o f  v e s i c u l a r  s t o ma t i t i s  v i r u s  M  p r o t e i n  i n  t h e  c y t o s o l  o f  
i n f e c t e d  c e l l s  o r  i s o l a t e d  f r o m v i r i o n s . "  
J  V i r o l  6 4 ( 2 ) : 9 0 2 - 6  
 
M c M a h o n ,  H . T .  a n d  J . L .  G a l l o p  ( 2 0 0 5 ) .  
" M e m b r a n e  c u r v a t u r e  a n d  m e c h a n i sms  o f  d y n a mi c  c e l l  me mb r a n e  
r e mo d e l l i n g . "  
N a t u r e  4 3 8 ( 7 0 6 8 ) : 5 9 0 - 5 9 6  
 
M c M a h o n ,  H . T .  a n d  I . G .  M i l l s  ( 2 0 0 4 ) .  
" C O P  a n d  c l a t h r i n - c o a t e d  v e s i c l e  b u d d i n g :  d i f f e r e n t  p a t h w a y s ,  
c o m mo n  a p p r o a c h e s . "  
C u r r  O p i n  C e l l  B i o l  1 6 ( 4 ) : 3 7 9 - 9 1  
 
M e l i k o v ,  K . C . ,  V . A .  F r o l o v ,  A .  S h c h e r b a k o v ,  A . V .  S a m s o n o v ,  Y . A .  
C h i z ma d z h e v  a n d  L . V .  C h e r n o mo r d i k  ( 2 0 0 1 ) .  
" V o l t a g e - i n d u c e d  n o n c o n d u c t i v e  p r e - p o r e s  a n d  m e t a s t a b l e  s i n g l e  
p o r e s  i n  u n mo d i f i e d  p l a n a r  l i p i d  b i l a y e r . "  
B i o p h y s  J  8 0 ( 4 ) : 1 8 2 9 - 3 6  
 
M o u r i t s e n ,  O . G .  ( 2 0 0 5 )  L i f e - a s  a  M a t t e r  o f  f a t : T h e  e m e r g i n g  
s c i e n c e  o f  l i p i d o m i c s ,  S p r i n g e r - V e r l a g  N e w  Y o r k ,  L L C .  
 
M u e l l e r ,  P .  a n d  D . O .  R u d i n  ( 1 9 6 7 ) .  
" A c t i o n  p o t e n t i a l  p h e n o me n a  i n  e x p e r i m e n t a l  b i m o l e c u l a r  l i p i d  
m e m b r a n e s . "  





M u i ,  B . L . ,  P . R .  C u l l i s ,  E . A .  E v a n s  a n d  T . D .  M a d d e n  ( 1 9 9 3 ) .  
" O s m o t i c  p r o p e r t i e s  o f  l a r g e  u n i l a me l l a r  v e s i c l e s  p r e p a r e d  b y  
e x t r u s i o n . "  
B i o p h y s  J  6 4 ( 2 ) : 4 4 3 - 5 3  
 
M u l l e n ,  J . T .  a n d  K . K .  T a n a b e  ( 2 0 0 2 ) .  
" V i r a l  o n c o l y s i s . "  
O n c o l o g i s t  7 ( 2 ) : 1 0 6 - 1 9  
 
N e h e r ,  E .  a n d  B .  S a k m a n n  ( 1 9 9 2 ) .  
" T h e  p a t c h  c l a mp  t e c h n i q u e . "  
S c i  A m  2 6 6 ( 3 ) : 4 4 - 5 1  
 
N e i t c h e v ,  V . Z .  a n d  L . P .  D u m a n o v a  ( 1 9 9 2 ) .  
" E f f e c t s  o f  t h e  c o mp o n e n t s  o f  N e w c a s t l e  d i s e a s e  v i r u s  o n  t h e  
s t r u c t u r a l  o r d e r  o f  l i p i d  a s s e mb l i e s . "  
M o l  B i o l  R e p  1 6 ( 1 ) : 2 7 - 3 1  
 
P a l a d e ,  G .  ( 1 9 7 5 ) .  
" I n t r a c e l l u l a r  A s p e c t s  o f  t h e  P r o c e s s  o f  P r o t e i n  S y n t h e s i s . "  
S c i e n c e  1 8 9 ( 4 2 0 0 ) :  347-58 
 
P a l a d e ,  G . E .  ( 1 9 5 3 ) .  
" A n  e l e c t r o n  m i c r o s c o p e  s t u d y  o f  t h e  m i t o c h o n d r i a l  s t r u c t u r e . "  
J  H i s t o c h e m  C y t o c h e m  1 ( 4 ) : 1 8 8 - 2 1 1  
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HOW MUCH OF THE LUV SURFACE SHOULD BE COVERED BY 
THE M PROTEIN CLUSTER TO PRODUCE THE VESICLE 
BURSTING? 
 
Let us consider a large unilamellar vesicle (LUV) of the radius R = 50 nm and 
initial area, S (Figure Appendix A(a)). If the protein clustering induces a cap which has 
the same curvature as a sphere of the radius R’= 150 nm (Figure Appendix A (b)), the 
LUV’s area covered by this cap may be defined as Snew=S1+S2, where (S1+S2) ≥ S, as 
shown in Figure Appendix A. The LUV area covered by this cap will increase as a 
function of the percent of its coverage by the protein. This relationship is shown in the 
Figure Appendix B. In 1993, Mui and coauthors showed that 3% increase of the initial 
area of the LUV is enough to produce vesicle bursting. Thus, when Snew/S = 1.03 (shown 
in blue in Figure Appendix B and schematically in A (c)), the bursting of the vesicle 
takes place. This relationship in areas corresponds to the 10-15% coverage of the LUV 
area by the protein cap, as can be observed in Figure Appendix B. 
 
Figure Appendix. A. Schematic representation of the bursting of an LUV induced by the protein cap 
formation. B. The relationship between the LUV surface coverage and the corresponding LUV area 
increase. LUV radius was assumed to be 50 nm. Protein cap was assumed to have the same curvature as a 
sphere with the radius of 150 nm. 
 
  
 
 
 
 
